# EDGAR Filing Document

**Accession Number:** 0001840317
**File Stem:** 0001213900-25-111013
**Filing Date:** 2025-11
**Character Count:** 168240
**Document Hash:** 206311dc625d3e2e8e5c750a8cbf144c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-111013.hdr.sgml**: 20251114

**ACCESSION NUMBER**: 0001213900-25-111013

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 80

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251114

**DATE AS OF CHANGE**: 20251114

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** VEEA INC.
- **CENTRAL INDEX KEY:** 0001840317
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 463921281
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40218
- **FILM NUMBER:** 251487913

**BUSINESS ADDRESS:**
- **STREET 1:** 164 E. 83RD STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10028
- **BUSINESS PHONE:** (212) 535-6050

**MAIL ADDRESS:**
- **STREET 1:** 164 E. 83RD STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10028

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Plum Acquisition Corp. I
- **DATE OF NAME CHANGE:** 20210113

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON D.C. 20549**

**FORM 10-Q**

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the Quarterly Period Ended September 30, 2025**

**OR**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from _______ to ________.**

**Commission file number: <u>001-40218</u>**

**VEEA INC.**

**(Exact name of Registrant as specified in its charter)**

---

| | |
|:---|:---|
| **Delaware** | **98- 1577353** |
| (State or other jurisdiction of | (I.R.S. Employer |
| incorporation or organization) | Identification No.) |

---

---

| | |
|:---|:---|
| **164 E. 83rd Street, <br> New York, NY** | **10028** |
| (Address of principal executive offices) | (Zip Code) |

---

**Registrant's telephone number, including area code: (212) 535-6050**

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock, par value $0.0001 per share | VEEA | The Nasdaq Stock Market LLC |
| Warrants, each whole warrant exercisable for one Common Stock at an exercise price of $11.50 per share | VEEAW | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company, and emerging growth company in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer ☐ Accelerated Filer ☐ <br> Non-Accelerated Filer ☒ Smaller Reporting Company ☒ <br> Emerging Growth Company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No

As of November 14, 2025, there were 50,160,673 shares of the registrant's common stock outstanding and 11,640,502 warrants outstanding.

**VEEA INC.**

**FORM 10-Q**

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
|  |  | **Page** |
| [**PART I. FINANCIAL INFORMATION**](#KJ_001) | [**PART I. FINANCIAL INFORMATION**](#KJ_001) | 1 |
| ITEM 1. | [Financial Statements](#KJ_002) | 1 |
|  | [Condensed Consolidated Balance Sheet as of September 30, 2025 (Unaudited) and December 31, 2024](#KJ_003) | 1 |
|  | [Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) for the Three and Nine Months Ended September 30, 2025 and 2024](#KJ_004) | 2 |
|  | [Unaudited Condensed Consolidated Statements of Changes in Stockholders' Deficit for the Three and Nine Months Ended September 30, 2025 and 2024](#KJ_005) | 3 |
|  | [Unaudited Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2025 and 2024](#KJ_006) | 5 |
|  | [Notes to Unaudited Condensed Consolidated Financial Statements](#KJ_007) | 6 |
| ITEM 2. | [Management's Discussion and Analysis of Financial Condition and Results of Operations](#KJ_008) | 27 |
| ITEM 3. | [Quantitative and Qualitative Disclosures about Market Risk](#KJ_009) | 37 |
| ITEM 4. | [Controls and Procedures](#KJ_010) | 37 |
| [**PART II. OTHER INFORMATION**](#KJ_011) | [**PART II. OTHER INFORMATION**](#KJ_011) | 38 |
| ITEM 1. | [Legal Proceedings](#KJ_012) | 38 |
| ITEM 1A. | [Risk Factors](#KJ_013) | 38 |
| ITEM 2. | [Unregistered Sales of Equity Securities and Use of Proceeds](#KJ_014) | 39 |
| ITEM 3. | [Defaults Upon Senior Securities](#KJ_015) | 39 |
| ITEM 4. | [Mine Safety Disclosures](#KJ_016) | 39 |
| ITEM 5. | [Other Information](#KJ_017) | 39 |
| ITEM 6. | [Exhibits](#KJ_019) | 40 |
| [**SIGNATURES**](#KJ_018) | [**SIGNATURES**](#KJ_018) | 41 |

---

i

**PART I. FINANCIAL INFORMATION**

**Item 1. Financial Statements**

**VEEA INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

---

| | | |
|:---|:---|:---|
|  | **September 30,**<br>**2025** | **December 31,**<br>**2024** |
|  | **(unaudited)** | |
| **ASSETS** |  |  |
| Cash | $1071151 | $1685633 |
| Receivables, net | 147438 | 84655 |
| Inventory, net | 9562118 | 7459240 |
| Prepaid and other current assets | 5535918 | 5649594 |
| **Total current assets** | **16316625** | **14879122** |
| Property and equipment, net | 113472 | 210629 |
| Goodwill | 5174240 | 4779625 |
| Intangible assets, net | 7594415 | 786061 |
| Investments | 236519 | 235596 |
| Other assets | 33879 | 202862 |
| **TOTAL ASSETS** | $**29469150** | $**21093895** |
| **LIABILITIES AND STOCKHOLDERS' DEFICIT** |  |  |
| Revolving line of credit | $14000000 | $12700000 |
| Accounts payable | 3553569 | 1290824 |
| Accrued expenses | 1202859 | 1911722 |
| Related party liabilities | 4057200 | 3657600 |
| Share issuance liability | - | 250000 |
| Deferred payables, current | 2257457 | 204445 |
| Notes payable | 1762415 | - |
| Convertible note payable, net ,current | 1550401 | - |
| Other current liabilities | - | 121579 |
| **Total current liabilities** | **28383901** | **20136171** |
| Convertible note payable, net | - | 37316 |
| Conversion option liability | - | 60000 |
| Warrant liability | 3310724 | 840995 |
| Earn-out Share Liability | 2040000 | 15560000 |
| Deferred payables | - | 1484238 |
| **TOTAL LIABILITIES** | **33734625** | **38118720** |
| **STOCKHOLDERS' DEFICIT** |  |  |
| Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding | - | - |
| Common Stock, $0.0001 par value, 551,000,000 shares authorized; and 50,160,673 and 36,202,798 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively | 5018 | 3621 |
| Additional paid-in capital | 214938054 | 200667682 |
| Accumulated deficit | (219567030) | (217830518) |
| Accumulated other comprehensive income | 358483 | 134391 |
| **TOTAL STOCKHOLDERS' DEFICIT** | **(4265475)** | **(17024825)** |
| **TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT** | $**29469150** | $**21093895** |

---

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

**VEEA INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)**

**(Unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the<br> Three Months Ended<br> September 30,** | **For the<br> Three Months Ended<br> September 30,** | **For the<br> Nine Months Ended<br> September 30,** | **For the<br> Nine Months Ended<br> September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Sales, net | $144926 | $50683 | $232094 | $108264 |
| Cost of goods sold | 53006 | 14997 | 58156 | 57687 |
| &nbsp;&nbsp;&nbsp;**Gross profit** | **91920** | **35686** | **173938** | **50577** |
| Operating Expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Product development | - | 356761 | 164878 | 1152930 |
| &nbsp;&nbsp;&nbsp;Sales and marketing | 15555 | 80937 | 364856 | 459341 |
| &nbsp;&nbsp;&nbsp;General and administrative, net | 4522588 | 1989095 | 14531883 | 13091503 |
| &nbsp;&nbsp;&nbsp;Transaction costs | - | 55038544 | 25000 | 55038544 |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 216436 | 67730 | 421096 | 205111 |
| Total operating expenses | 4754579 | 57533067 | 15507713 | 69947429 |
| &nbsp;&nbsp;&nbsp;**Loss from operations** | **(4662659)** | **(57497381)** | **(15333775)** | **(69896852)** |
| **Other income (expense):** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Other income | 879 | 8739 | 2112 | 21398 |
| &nbsp;&nbsp;&nbsp;UK R&D tax credit | 1223328 | 1251243 | 1223328 | 1251243 |
| &nbsp;&nbsp;&nbsp;Loss on initial issuance of convertible note | - | (1770933) | - | (1770933) |
| &nbsp;&nbsp;&nbsp;Change in fair value of convertible note option liability | 270 | 607067 | 60000 | 607067 |
| &nbsp;&nbsp;&nbsp;Change in fair value of warrant liabilities | 555498 | (220373) | 660622 | (220373) |
| &nbsp;&nbsp;&nbsp;Change in fair value of Earn-out Share Liability | 4720000 | 24750000 | 13520000 | 24750000 |
| &nbsp;&nbsp;&nbsp;Other expense | (19155) | (36) | (46351) | (9346) |
| &nbsp;&nbsp;&nbsp;Interest expense | (442867) | (451881) | (1822448) | (1352823) |
| &nbsp;&nbsp;&nbsp;**Total other income** | 6037953 | 24173826 | 13597263 | 23276233 |
| **Net income (loss)** | $**1375294** | **(33323555)** | **(1736512)** | **(46620619)** |
| Net income (loss) per share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic | $0.03 | $(1.49) | $(0.04) | (2.31) |
| &nbsp;&nbsp;&nbsp;Diluted | $0.03 | $(1.49) | $(0.04) | (2.31) |
| Weighted-average common stock outstanding used in per share amounts: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic | 45644909 | 22292374 | 40325293 | 20217081 |
| &nbsp;&nbsp;&nbsp;Diluted | 45670396 | 22292374 | 40325293 | 20217081 |
| **Other comprehensive income (loss):** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Foreign currency translation adjustment | 35099 | (1597335) | 224092 | (1109232) |
| **Comprehensive income (loss)** | $**1410393** | $**(34920890)** | $**(1512420)** | $**(47729851)** |

---

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

**VEEA INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT**

**(Unaudited)**

**FOR THE THREE MONTHS ENDED SEPTEEMBER 30, 2025**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Common Stock** | **Common Stock** | | | | |
|  | **Shares** | **Amount** | **Additional<br> Paid-in-**<br>**Capital** | **Accumulated**<br>**Deficit** | **Accumulated<br> Other<br> Comprehensive**<br>**Income** | **Total<br> Stockholders'**<br>**Deficit** |
| **Balance, June 30, 2025** | 40926445 | $4094 | $209682257 | $(220942324) | $323384 | $(10932589) |
| Stock based compensation |  | - | 319211 | - | - | 319211 |
| Common stock issued in connection with public offering, net of transaction costs | 9189096 | 919 | 4936583 | - | - | 4937502 |
| Common stock issued upon exercise of stock options | 14529 | 1 | 6 | - | - | 7 |
| Common stock issued upon vesting of RSUs | 30603 | 4 | (3) | - | - | 1 |
| Foreign currency translation gain |  | - | - | - | 35099 | 35099 |
| Net income | - | - | - | 1375294 | - | 1375294 |
| **Balance, September 30, 2025** | 50160673 | $5018 | $214938054 | $(219567030) | $358483 | $(4265475) |

---

**FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2024**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Common Stock** | **Common Stock** | | | | |
|  | **Shares** | **Amount** | **Additional<br> Paid-in-**<br>**Capital** | **Accumulated**<br>**Deficit** | **Accumulated<br> Other<br> Comprehensive**<br>**Loss** | **Total<br> Stockholders'**<br>**Deficit** |
| **Balance, June 30, 2024** | 21357113 | $2136 | $172052711 | $(183579814) | $(173251) | $(11698218) |
| Stock based compensation |  | - | 59385 | - | - | 59385 |
| Common stock issued upon exercise of stock options, pre Business Combination | 19618 | 2 | 53998 | - | - | 54000 |
| Exercise of Common Stock Warrants - related party | 756912 | 76 | (76) | - | - | - |
| Issuance of Common Stock in exchange for services in connection with A-2 Preferred Stock Issuances, recasted | 615385 | 61 | (61) | - | - | - |
| Issuance of Common Stock upon conversion of debt at Business Combination | 3147970 | 315 | 15739531 | - | - | 15739846 |
| Issuance of Common Stock upon conversion of Sponsor and related party notes and warrants at Business Combination | 817453 | 82 | 2205415 | - | - | 2205497 |
| Issuance of Common Stock to Plum Sponsors and Investors at Business Combination | 6102562 | 610 | 241638 | - | - | 242248 |
| Issuance of Common Stock to Plum Shareholders at Business Combination | 603077 | 60 | (6901658) |  |  | (6926598) |
| Issuance of Common Stock related to new financing | 2000000 | 200 | 23999800 |  |  | 24000000 |
| Common Stock issued for services | 241667 | 24 | 3214596 |  |  | 3214620 |
| Common stock issued upon exercise of stock options, post Business Combination | 25000 | 2 | (2) | - | - | - |
| Foreign currency translation loss |  |  |  |  | (1597335) | (1597335) |
| Net loss |  |  |  | (33323555) | - | (33323555) |
| **Balance, September 30, 2024** | 35686757 | $3568 | $210665277 | $(216903369) | $(1770586) | $(8005110) |

---

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

**VEEA INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT**

**(Unaudited)**

**FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2025**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Common Stock** | **Common Stock** | | | | |
|  | **Shares** | **Amount** | **Additional<br> Paid-in-**<br>**Capital** | **Accumulated**<br>**Deficit** | **Accumulated<br> Other<br> Comprehensive**<br>**Income** | **Total<br> Stockholders'**<br>**Deficit** |
| **Balance, December 31, 2024** | 36202798 | $3621 | $200667682 | $(217830518) | $134391 | $(17024824) |
| Stock based compensation |  |  | 759123 |  |  | 759123 |
| Common stock issued in connection with public offering, net of transaction costs | 9189096 | 919 | 4936583 |  |  | 4937502 |
| Common stock issued upon exercise of stock options | 32806 | 2 | 16 |  |  | 18 |
| Common stock issued upon vesting of RSUs | 91453 | 10 | (9) |  |  | 1 |
| Common stock issued upon draw on the equity line of credit | 358000 | 37 | 836730 |  |  | 836767 |
| Common stock issued as compensation for equity line of credit commitment fee | 27498 | 3 | 24997 |  |  | 25000 |
| Common stock issued as consideration for Crowdkeep | 4065689 | 407 | 6829951 |  |  | 6830358 |
| Common stock issued for services | 100000 | 10 | 182990 |  |  | 183000 |
| Settlement of convertible note agreement for shares issued | 93333 | 9 | 699991 |  |  | 700000 |
| Foreign currency translation gain |  |  |  |  | 224092 | 224092 |
| Net loss |  |  |  | (1736512) |  | (1736512) |
| **Balance, September 30, 2025** | 50160673 | $5018 | $214938054 | $(219567030) | $358483 | $(4265475) |

---

**FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2024**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Common Stock** | **Common Stock** | | | | |
|  | **Shares** | **Amount** | **Additional<br> Paid-in-**<br>**Capital** | **Accumulated**<br>**Deficit** | **Accumulated<br> Other<br> Comprehensive**<br>**Loss** | **Total<br> Stockholders'**<br>**Deficit** |
| **Balance, December 31, 2023** | 19635912 | $1964 | $159475010 | $(170282750) | $(661354) | $(11467130) |
| Class A Common Stock Issuances, net of transaction costs | 1675502 | 168 | 11955239 | - | - | 11955407 |
| Common stock issuances, net of transaction costs | 7297 | 2 | 54725 |  |  | 54725 |
| Conversion of vendor payable to Common Stock | 27654 | 1 | 207405 | - | - | 207408 |
| Common stock issued upon exercise of stock options | 10748 | 1 | 25483 | - | - | 25484 |
| Stock based compensation |  | - | 394234 | - | - | 394234 |
| Common stock issued upon exercise of stock options, pre Business Combination | 19618 | 2 | 53998 | - | - | 54000 |
| Exercise of Common Stock Warrants - related party | 756912 | 76 | (76) | - | - | - |
| Issuance of Common Stock in exchange for services in connection with A-2Preferred Stock Issuances, recasted | 615385 | 61 | (61) | - | - | - |
| Issuance of Common Stock upon conversion of debt at Business Combination | 3147970 | 315 | 15739531 | - | - | 15739846 |
| Issuance of Common Stock upon conversion of Sponsor and related party notes and warrants at Business Combination | 817453 | 82 | 2205415 | - | - | 2205497 |
| Issuance of Common Stock to Plum Sponsors and Investors at Business Combination | 6102562 | 610 | 241638 | - | - | 242248 |
| Issuance of Common Stock to Plum Shareholders at Business Combination | 603077 | 60 | (6901658) |  |  | (6926598) |
| Issuance of Common Stock related to new financing | 2000000 | 200 | 23999800 |  |  | 24000000 |
| Common Stock issued for services | 241667 | 24 | 3214596 |  |  | 3214620 |
| Common stock issued upon exercise of stock options, post Business Combination | 25000 | 2 | (2) | - | - | - |
| Foreign currency translation loss |  |  |  |  | (1109232) | (1109232) |
| Net loss |  |  |  | (46620619) | - | (46620619) |
| **Balance, September 30, 2024** | 35686757 | $3568 | $210665277 | $(216903369) | $(1770586) | $(8005110) |

---

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

**VEEA INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
|  | **Nine Months Ended<br> September 30,** | **Nine Months Ended<br> September 30,** |
|  | **2025** | **2024** |
| **Cash flows from operating activities** |  |  |
| Net loss | $(1736512) | $(46620619) |
| Adjustments to reconcile net loss to net cash used for operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 421096 | 205111 |
| &nbsp;&nbsp;&nbsp;Amortization of debt issuance costs | 963085 | 45648 |
| &nbsp;&nbsp;&nbsp;Loss on initial issuance of debt | - | 1770933 |
| &nbsp;&nbsp;&nbsp;Change in fair value of convertible note option liability | (60000) | (607067) |
| &nbsp;&nbsp;&nbsp;Change in fair value of warrant liabilities | (660622) | 220373 |
| &nbsp;&nbsp;&nbsp;Earn-out liability initial loss | - | 53600000 |
| &nbsp;&nbsp;&nbsp;Change in fair value of Earn-out Share Liability | (13520000) | (24750000) |
| &nbsp;&nbsp;&nbsp;Interest income on investment | - | (768) |
| &nbsp;&nbsp;&nbsp;Share based compensation | 759123 | 394234 |
| &nbsp;&nbsp;&nbsp;Share based vendor payments as compensation for services | 183000 | - |
| &nbsp;&nbsp;&nbsp;Share based payment as compensation for ELOC commitment fee | 25000 |  |
| &nbsp;&nbsp;&nbsp;Interest expense on convertible notes converted | - | 868853 |
| &nbsp;&nbsp;&nbsp;Unrealized foreign currency transaction (gain) loss | (218537) | (1686348) |
| &nbsp;&nbsp;&nbsp;Amortization of operating lease right of use assets | 117365 | 340496 |
| Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Receivables | (62498) | (31736) |
| &nbsp;&nbsp;&nbsp;Inventories | (705230) | (602235) |
| &nbsp;&nbsp;&nbsp;Prepaid and other current assets | 119002 | (5034546) |
| &nbsp;&nbsp;&nbsp;Other assets | 53493 | - |
| &nbsp;&nbsp;&nbsp;Accounts payable | 2576523 | 793161 |
| &nbsp;&nbsp;&nbsp;Accrued expenses | (216700) | 1618881 |
| &nbsp;&nbsp;&nbsp;Other liabilities | 569269 | - |
| &nbsp;&nbsp;&nbsp;Operating lease payments | (121579) | (353929) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in operating activities | (11514722) | (19829558) |
| **Cash flows from investing activities** |  |  |
| &nbsp;&nbsp;&nbsp;Purchase of property and equipment | - | (33439) |
| &nbsp;&nbsp;&nbsp;Purchase of intangible assets and trademarks | (224949) | (174258) |
| Net cash used in investing activities | (224949) | (207697) |
| **Cash flows from financing activities** |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from revolving line of credit | 1300000 | 3700000 |
| &nbsp;&nbsp;&nbsp;Proceeds from related party notes | 3176000 | - |
| &nbsp;&nbsp;&nbsp;Proceeds from issuance of convertible notes | 1000000 | 1450000 |
| &nbsp;&nbsp;&nbsp;Proceeds from the issuance of shares under equity line of credit facility | 836766 |  |
| &nbsp;&nbsp;&nbsp;Proceeds from reverse recapitalization | - | 1103640 |
| &nbsp;&nbsp;&nbsp;Proceeds from lock-up share release | - | 242248 |
| &nbsp;&nbsp;&nbsp;Proceeds from the issuance of common stock, net of transaction costs | 4828750 | 9961356 |
| &nbsp;&nbsp;&nbsp;Proceeds from exercise of stock options for common stock | 19 | 79484 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by financing activities | 11141535 | 16536728 |
| **Effect of exchange rate changes on cash** | (16346) | 293421 |
| Net decrease in cash and cash equivalents | (614482) | (3207105) |
| Cash and cash equivalents at beginning of period | 1685633 | 6010075 |
| Cash and cash equivalents at end of period | $1071151 | $2802970 |
| **Non-cash activities** |  |  |
| Initial measurement of debt discount on the convertible note | - | (1450000) |
| Conversion of related party notes to Common Stock | 3176000 | 2205497 |
| Conversion of interest on related party notes to Common Stock | 63096 | 3141846 |
| Initial measurement of the convertible note option liability | - | 1450000 |
| Conversion of principal on related party notes to Common Stock | - | 12598000 |
| Crowdkeep asset acquisition | 6957456 | - |
| Settlement of convertible notes for shares issued | 700000 | 24000000 |
| Conversion of vendor payable to Common Stock | - | 3422028 |
| &nbsp;&nbsp;&nbsp;**Supplemental cash flow information** |  |  |
| Interest paid | 640441 | 504431 |

---

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

**Veea Inc. and Subsidiaries**

**Notes to the Condensed Consolidated Financial Statements** 

**1 - DESCRIPTION OF BUSINESS** 

The Company is dedicated to simplifying the journey towards creating a world in which virtually everyone and everything is intelligently connected, while bringing applications and artificial intelligence to the edge of the network. Most service providers, equipment suppliers, system integrators and even hyperscalers have adopted or advocated for similar solutions to various degrees either independently or in collaboration with the Company. However, to our knowledge, we are the first to market with patented technologies that (a) bring virtualized data center capabilities to the far edge of the network, commonly referred to as the Device Edge, where all wired and wireless devices connect to the network, (b) spawns hyperconvergence of computing, multiaccess communications and storage, (c) provides for Cloud-managed applications at the Edge ("Hybrid Edge-Cloud Computing"), and (d) enables machine learning with AI training, inferencing, and agentic AI at the edge ("Edge AI") including AI-driven cybersecurity for heterogenous networks. Such networks have given rise through any combination of our developed devices and third-party devices, with CPUs, GPUs, TPUs, DPUs and/or NPUs, that run on the VeeaONE platform's software stack. Our end-to-end edge-cloud platform is referred to as VeeaONETM ("VeeaONE") platform.

Veea has developed several generations of highly integrated all-in-one devices that incorporate a Linux server, with a virtualized software environment, supporting our patented secured docker containers, together with a Wi-Fi Access Point with a mesh router, a firewall, an IoT gateway, NVMe data storage and 4G/5G modules. With an extensive patent portfolio of 123 granted patents and 32 pending patent applications that cover 26 patent families, our end-to-end Hybrid Edge-Cloud Computing platform represents a new product category that has the potential for wide scale customer adoption in large segments of consumer and enterprise markets.

VeeaONE platform's products, applications, and services with a distributed computing architecture, offered as a Platform-as-a-Service capability, empowering companies to capitalize on the transformative potential of Edge AI, where most of the data from smartphones, tablets, laptops, cameras, sensors, and other devices is generated, with data privacy and sovereignty, reliability, low latency for real-time decisions, bandwidth efficiency, scalability, and reduced costs compared to alternatives.

VeeaHub products, about the size of a typical Wi-Fi Access Point, are offered in variety of form factors with different capabilities for indoor and outdoor coverage and are both locally- and cloud-managed. VeeaONE architecture and business model, VeeaHub and third-party devices on VeeaONE platform with Hybrid Edge-Cloud Computing and AI-enabled applications and services.

The VeeaONE platform offers an alternative to cloud computing by enabling the formation of highly secure, but easily accessible, private clouds and networks across one or multiple user(s) or enterprise location(s) across the globe. The benefits include optimal latency, lower data transport costs, data privacy, security and ownership, Edge AI, as well as "always-on" availability for mission critical applications, and contextual awareness for people, devices and things connected to the Internet.

Our products and services have been deployed across multiple countries and industries; however, we are focused on high-growth market segments such as fixed-line or 5G-based fixed wireless broadband access, and subscription-based managed Wi-Fi for unserved and underserved communities. In both cases, broadband or Internet connectivity services are offered with a variety of Edge applications and value-added services, including advanced AI-driven cybersecurity, through Mobile Network Operators, Multiple System Operators, Internet Service Providers and other types of Managed Service Providers. The industrial applications include climate smart buildings, smart farming with precision agriculture, smart warehouses and smart retail as cloud-managed converged private networks.

Gartner recognized the innovativeness and capabilities of the platform by naming the Company a Leading Smart Edge Platform in 2023 and Cool Vendor in Edge Computing in 2021. Market Reports World in its research report published in October 2023 named the Company as one of the top 10 Edge AI solution providers alongside of IBM, Microsoft, Amazon Web Services and others.

Private Veea was founded in 2014 by Allen Salmasi, our Chief Executive Officer and a pioneering wireless technology leader. Mr. Salmasi helped to drive industry transformation through his contributions to the development of CDMA/TDMA-based OmniTRACS, the largest mobile satellite messaging and position reporting system with integrated IoT solutions during the 1980s and 1990s; CDMA-based 2G/3G technologies and products at Qualcomm in 1990s; OFDMA-based 4G technologies and products at NextWave during the 2000s, and hyper-converged edge computing and communications during the 2010s; and beyond with the Company.

The Company has six wholly owned subsidiaries, VeeaSystems Inc., formerly known as Veea Inc. a Delaware corporation, ("Private Veea"), Veea Solutions Inc., a Delaware corporation, VeeaSystems Development Inc., formerly known as Veea Systems Inc., a Delaware corporation, Veea Systems Ltd., a company organized under the laws of England and Wales, VeeaSystems SAS, a French simplified joint stock company and VeeaSystems CK Inc., a Delaware corporation; and one majority owned subsidiary, VeeaSystems Mexico, S. de R.L. de C.V., a limited capital company organized under the laws of Mexico ("VeeaSystems MX"). VeeaSystems MX is 95% owned by VeeaSystems Inc., and due to local law requirements, the remaining 5% is held by the Company's CEO. The Company is headquartered in New York City with offices in the United States, Mexico and Europe.

**2 - LIQUIDITY AND MANAGEMENT'S PLAN**

During the three months ended September 30, 2025 and 2024, the Company incurred operating losses of $4.7 million and $57.5 million, respectively, and during the nine months ended September 30, 2025 and 2024, the Company incurred operating losses of $15.3 million and $69.9 million, respectively, and had an accumulated deficit of $219.6 million as of September 30, 2025. Since its inception, it has incurred significant operating losses and negative cash flows. The Company expects to continue to incur net losses as it continues to grow and scale its business. As of September 30, 2025, it had cash of $1,071,151 and outstanding debt of $17.5 million, of which $750,000 was outstanding under the September 2024 Notes (as defined below), $1.0 million was outstanding under the Crowdkeep Convertible Notes (as defined below), $14.0 million was outstanding under the working capital facility, and $1.8 million was outstanding under a notes payable with an inventory vendor.

Although the Company has had recurring losses each year since inception, the Company plans to fund its operations and capital funding needs for the next 12 months with revenue generated from operations and through a combination of private and public equity offerings including, without limitation, anticipated revenue generated under the Supply Agreement entered into with Telcel, the proceeds of the Company's Common Stock Offering completed on August 14, 2025, receipt of the cash tax refund of approximately $1.2 million in respect of the Company's UK subsidiary's 2023 and 2024 research and development activities, and potential additional investments in the form of debt or equity to fund operating deficits from existing and/or new investors, including related parties, which may include the Company's CEO and his affiliates.

Based in part on the above-referenced opportunities and initiatives, the Company has a reasonable basis to believe it has alleviated substantial doubt regarding its ability to continue as a going concern. Although management continues to pursue these plans, there is no assurance that the Company will be successful in obtaining sufficient funding on terms acceptable to the Company, if at all.

**3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**

**Principles of Consolidation**

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and the rules and regulations of the U.S. Securities and Exchange Commission (the "SEC") for interim financial information. Accordingly, certain information and footnote disclosures normally included in consolidated financial statements in accordance with GAAP have been omitted. In the opinion of management, all adjustments considered necessary for a fair presentation have been included.

All significant intercompany balances and transactions have been eliminated in consolidation. We consolidate any variable interest entity ("VIE") where we have determined we are the primary beneficiary. The primary beneficiary is the entity which has both: (i) the power to direct the activities of the VIE that most significantly impact the VIE's economic performance; and (ii) the obligation to absorb losses or receive benefits of the entity that could potentially be significant to the VIE. The Company has one VIE, VeeaSystems MX. Transactions with VeeaSystems MX were immaterial during all the periods presented and are not separately disclosed.

The condensed consolidated balance sheet as of September 30, 2025, has been derived from the unaudited consolidated financial statements at that date, but does not include all disclosures, including notes required by GAAP for complete financial statements. The unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and accompanying footnotes included in the Company's Annual Report on Form 10-K for its year ended December 31, 2024.

**Basis of Accounting**

The accompanying condensed consolidated financial statements have been prepared on the accrual basis in accordance with accounting principles generally accepted under GAAP.

**Use of Estimates**

Management of the Company is required to make certain estimates, judgments, and assumptions during the preparation of its condensed consolidated financial statements in accordance with GAAP. The Company believes that these estimates, judgments and assumptions are reasonable under the circumstances. These estimates, judgments, and assumptions impact the reported amounts of assets, liabilities, revenue, and expenses, and the related disclosure of contingent assets and liabilities. Actual results could differ from these estimates. Changes in such estimates could affect amounts reported in future periods. On an ongoing basis, the Company evaluates its estimates and judgments including those related to: liquidity and going concern, the useful lives and recoverability of property and equipment and definite-lived intangible assets; the recoverability of goodwill and indefinite-lived intangible assets; the carrying value of accounts receivable, including the determination of the allowance for credit losses; inventory, including the determination of allowances for estimated excess or obsolescence; the fair value of warrants; the fair value of acquisition-related contingent consideration arrangements; the fair value of the ELOC; unrecognized tax benefits; legal contingencies; the incremental borrowing rate for the Company's leases; and the valuation of stock-based compensation, among others.

**Emerging Growth Company Status**

The Company is an emerging growth company, as defined in the JOBS Act. Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act, until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that it (i) is no longer an emerging growth company or (ii) affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, these financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates.

 

 

**Segment Information**

The Company operates as a single operating segment. The chief operating decision maker is the Company's Chief Executive Officer, who makes resource allocation decisions and assesses performance based on financial information presented on a consolidated basis, accompanied by disaggregated revenue information. Accordingly, the Company has determined that it has a single reportable segment and operating segment. The majority of the Company's assets as of September 30, 2025 and December 31, 2024, were attributable to its U.S. operations. The Company's long-lived assets are based on the physical location of the assets. For the three months and nine months ended September 30, 2025, revenue was negligible and not materially concentrated among customers.

**Recent Accounting Pronouncements**

In December 2023, the FASB issued ASU 2023-09, *Income Taxes (Topic 740): Improvements to Income Tax Disclosures*. The ASU requires that an entity disclose specific categories in the effective tax rate reconciliation as well as reconciling items that meet a quantitative threshold. Further, the ASU requires additional disclosures on income tax expense and taxes paid, net of refunds received, by jurisdiction. The new standard is effective for annual periods beginning after December 15, 2024, on a prospective basis with the option to apply it retrospectively. Early adoption is permitted. The adoption of this guidance results in the Company being required to include enhanced income tax-related disclosures. The Company adopted this guidance effective January 1, 2025; however, as there is a full valuation allowance on its deferred tax assets, income tax disclosures are not material to the condensed consolidated financial statements and are not included in this Quarterly Report on Form 10-Q but will be evaluated quarterly going forward necessary disclosures.

In November 2023, the FASB issued ASU 2023-07, *Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures*. This ASU includes amendments that expand the existing reportable segment disclosure requirements and requires disclosure of (i) significant expense categories and amounts by reportable segment as well as the segment's profit or loss measure(s) that are regularly provided to the chief operating decision maker (the "CODM") to allocate resources and assess performance; (ii) how the CODM uses each reported segment profit or loss measure to allocate resources and assess performance; (iii) the nature of other segment balances contributing to reported segment profit or loss that are not captured within segment revenues or expenses; and (iv) the title and position of the individual or name of the group or committee identified as the CODM. This guidance requires retrospective application to all prior periods presented in the financial statements and is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The adoption of this guidance results in the Company being required to include enhanced disclosures relating to its reportable segments. The Company adopted this guidance effective December 31, 2024, and it did not have a material effect on the Company's condensed consolidated financial statements.

In November 2024, the FASB issued ASU No. 2024-03, *Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40).* In January 2025, the FASB issued ASU 2025-01, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date to clarify the effective date of ASU 2024-03. The amendments in this ASU require a public business entity to disclose specific information about certain costs and expenses in the notes to its financial statements for interim and annual reporting periods. The objective of the disclosure requirements is to provide disaggregated information about a public business entity's expenses to help investors (a) better understand the entity's performance, (b) better assess the entity's prospects for future cash flows, and (c) compare an entity's performance over time and with that of other entities. The additional disclosures under this update include (1) disclosing the amounts of purchases of inventory, employee compensation, depreciation, intangible asset amortization, and depreciation, depletion, and amortization recognized as part of oil and gas-producing activities (DD&A) (or other amounts of depletion expense) that are included in each relevant expense caption, (2) include certain amounts that are already required to be disclosed under current generally accepted accounting principles (GAAP) in the same disclosure as the other disaggregation requirements, (3) disclose a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively, and (4) disclose the total amount of selling expenses and, in annual reporting periods, an entity's definition of selling expenses. The amendments in this ASU are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of this ASU on its condensed consolidated financial statements.

**4 - ACQUISITION**

On May 13, 2025, the Company entered into an Asset Purchase Agreement with Crowdkeep, Inc., a Delaware corporation (the "Seller"), pursuant to which the Company acquired certain assets of Seller relating to Seller's IoT technology platform business, free and clear of any liens other than certain specified liabilities of Seller that were assumed. In consideration for the acquisition, the Company issued 4,065,689 shares of its Common Stock (the "Purchase Price").

The transaction was accounted for as an asset acquisition, as the Company determined that substantially all of the fair value was concentrated in a single identifiable intangible asset, proprietary technology, and therefore applied a model consistent with asset acquisition accounting. The total purchase consideration of $6,957,456 was comprised of equity consideration of $6,830,358 based on the number of shares issued at the closing share price, and direct acquisition-related costs for legal and advisory fees of $127,098, the total of which was allocated to the acquired assets on a relative fair value basis. Because this was not a business combination, no goodwill was recognized.

The transaction was considered a related party transaction due to the involvement of a Company board member who was also the CEO and shareholder of Crowdkeep. The Company established a special committee of the Board comprised of independent members of the Board, that evaluated and approved the transaction, concluding that the terms were commercially reasonable and negotiated at arm's length.

The patented technology, which is recorded as part of intangible assets, net in the condensed consolidated balance sheet, will be amortized over its estimated useful life of 10 years.

**5 - REVERSE RECAPITALIZATION**

As discussed in Note 1, the Business Combination was consummated on September 13, 2024, which, for accounting and reporting purposes under GAAP, was treated as the equivalent of Private Veea issuing stock for the net assets of Plum, accompanied by an equity recapitalization of Private Veea, which was determined to fall within the scope of Accounting Standards Codification ("ASC") 805, "*Business Combinations*". Plum was treated as the acquired company, and its net assets were stated at historical cost, with no goodwill or other intangible assets recorded. The excess of the fair value of shares issued to Plum over the fair value of Plum's identifiable net assets acquired represented compensation for the service of a stock exchange listing for its shares and was expensed as incurred.

The warrants issued at the time of Plum's initial public offering (the "Public Warrants"), and warrants issued in connection with private placement at the time of Plum's initial public offering (the "SPAC Private Placement Warrants") remain outstanding and are now outstanding warrants for the Company.

 

*Earn-out Share Liability*

Following the Closing, stockholders who previously held certain capital stock of Private Veea have the contingent right to receive up to 4.5 million additional shares of the common stock, par value $0.0001 per share, of the Company ("Common Stock") if certain trading-price based milestones of the Company's Common Stock are achieved or a change of control transaction occurs during the ten-year period following the Closing.

Under accounting principles, the Company's obligation to issue the earn-out shares is recorded as a contingent liability (the "Earn-out Share Liability") in the Company's financial statements and the initial value of the Earn-out Share Liability was recorded as a transaction cost within operating expenses in the Company's financial statements for the year ended December 31, 2024. For each subsequent reporting period, changes in the fair value of the Earn-Out Share Liability are reported in the Company's financial statements.

**6 - BALANCE SHEET COMPONENTS**

**Inventory**

Inventory consists of the following:

---

| | | |
|:---|:---|:---|
|  | **September 30,<br> 2025** | **December 31,<br> 2024** |
| Inventory | $7724496 | $7377966 |
| Inventory allowance | (904653) | (904653) |
| Consigned parts | 2742275 | 985927 |
| &nbsp;&nbsp;&nbsp;Total | $9562118 | $7459240 |

---

**Property and Equipment, net**

Property and equipment, net consists of the following:

---

| | | |
|:---|:---|:---|
|  | **September 30,<br> 2025** | **December 31,<br> 2024** |
| Furniture and fixtures | $710241 | $702122 |
| Computer equipment | 335498 | 327166 |
| Leasehold improvements | 390742 | 390742 |
| &nbsp;&nbsp;&nbsp;Total property and equipment gross | 1436481 | 1420030 |
| Less - Accumulated depreciation | (1323009) | (1209401) |
| &nbsp;&nbsp;&nbsp;Total property and equipment net | $113472 | $210629 |

---

Depreciation expense for the three months ended September 30, 2025 and 2024, totaled $29,036 and $56,000, respectively. Depreciation expense for the nine months ended September 30, 2025 and 2024, totaled $106,425 and $166,000, respectively.

**7 - GOODWILL AND INTANGIBLE ASSETS**

**Goodwill**

The following is a summary of activity in goodwill for the nine months ended September 30, 2025 and 2024:

---

| | |
|:---|:---|
|  | **September 30,<br> 2025** |
| Balance at December 31, 2024 | $4779625 |
| Foreign exchange transactions | 394615 |
| Balance at September 30, 2025 | 5174240 |

---

---

| | |
|:---|:---|
|  | **September 30,<br> 2024** |
| Balance at December 31, 2023 | $4797078 |
| Foreign exchange transactions | 279713 |
| Balance at September 30, 2024 | 5076791 |

---

**Intangible Assets**

Intangible assets consist of the following:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** |
|  | **Amortization<br> Period** | **Costs as of<br> December 31,<br> 2024** | **Additions** | **Disposals** | **Ending<br> Costs** | **Accumulated<br> Amortization** | **Accumulated<br> Impairment** | **Net Book<br> Value** |
| Patents | 15 years | $7551468 | $218718 | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | $7770186 | $(6823892) | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | $946295 |
| Proprietary technology | 10 years | - | 6904306 | - | 6904306 | (256185) | - | 6648120 |
| Intangible assets, net |  | $7551468 | $7123024 | $- | $14674492 | $(7080077) | $- | $7594415 |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** |
|  | **Amortization**<br>**Period** | **Costs as of<br> January 1,**<br>**2024** |<br>**Additions** |<br>**Disposals** | **Ending**<br>**Costs** | **Accumulated**<br>**Amortization** | **Accumulated**<br>**Impairment** | **Net Book**<br>**Value** |
| Patents | 15 years | $7332227 | $219241 | $- | $7506485 | $(6765407) | $- | $786061 |
| IPR&D | 5 years | 5015694 | - | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- | 5015694 | (3554784) | (1460910) | - |
| Intangible assets, net |  | $12347921 | $219241 | $- | $12552179 | $(10320191) | $(1460910) | $786061 |

---

Intangible assets primarily consist of proprietary technology, patents, patent applications, and in-process research and development ("IPR&D") and other identifiable intangible assets. Intangible assets are generally amortized on a straight-line basis over the periods of benefit. The Company's patents have estimated remaining economic useful lives ranging from 5-15 years and the proprietary technology acquired from Crowdkeep Inc. has an estimated remaining useful life of 10 years. Management reviews intangible assets for impairment when events and circumstances warrant. During the nine months ended September 30, 2025 and 2024, there were no events that necessitated additional impairment of intangible assets.

Intangible asset amortization expense for the three months ended September 30, 2025 and 2024, totaled $187,400 and $11,000, respectively. Intangible asset amortization expense for the nine months ended September 30, 2025 and 2024, totaled $314,671 and $39,000, respectively.

Future estimated amortization expense for the Company's intangible assets is approximately as follows:

---

| | |
|:---|:---|
| **Future estimated amortization as of September 30, 2025** | |
| Remainder of 2025 | $187619 |
| 2026 | 742124 |
| 2027 | 742124 |
| 2028 | 743941 |
| 2029 | 742124 |
| Thereafter | 4436483 |
|  | $7594415 |

---

**8 - DEBT**

Total outstanding debt of the Company is comprised of the following, including convertible notes:

---

| | | | |
|:---|:---|:---|:---|
| **September 30, 2025** | **Principal** | **Debt<br> Discount** | **Total** |
| Revolving Loan Facility | $14000000 | $- | $14000000 |
| Convertible note payable, net | 1750000 | (199599) | 1550401 |
| Notes payable | 1762415 | - | 1762415 |
| Total | $17512415 | $(199599) | $17312816 |

---

---

| | | | |
|:---|:---|:---|:---|
| **December 31, 2024** | **Principal** | **Debt<br> Discount** | **Total** |
| Revolving Loan Facility | $12700000 | $- | $12700000 |
| Convertible note payable | 1200000 | (1102684) | 97316 |
| Total | $13900000 | $(1102684) | $12797316 |

---

**Revolving Loan Facility**

In June 2021, Private Veea entered into a revolving loan agreement (the "2021 Revolving Loan Agreement") with First Republic Bank, which was subsequently acquired by JPMorgan Chase, (the "Bank") providing up to $14.0 million of advances (collectively, the "Loan"). The Loan accrues interest at a variable rate based on an index rate established by reference to the average 12-month trailing one-year US treasuries plus a spread of 1.80% per annum and a minimum floor rate of 1.5% per annum. Interest is payable monthly in cash. Private Veea was not required to provide collateral for the advances or comply with any covenants. The advances were secured by a lien on certain personal assets of the CEO. In consideration for the security provided by the CEO, Private Veea issued common stock warrants (the "Related Party Common Stock Warrants") to NLabs, a principal shareholder of the Company and affiliate of Allen Salmasi ("NLabs"), in consideration for the CEO's guaranteeing the advances. See Note 12 for further information. In December 2023, Private Veea repaid $5,000,000 of the principal balance of the Loan. Following the acquisition of First Republic, the Loan was transferred to the Bank. There were no borrowings during the three months ended September 30, 2025, and $1.3 million of borrowings during the nine months ended September 30, 2025. As of September 30, 2025, the outstanding principal amount of the Loan was $14.0 million, and there is no availability to borrow additional funds.

**Convertible Notes Payable**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

***Business Combination Convertible Notes Payable***

Simultaneously with the closing of the Business Combination, the Company and Private Veea issued convertible notes under note purchase agreements (the "Note Purchase Agreements") with certain accredited investors unaffiliated with the Company and Private Veea (each, an "Investor") for the sale of unsecured subordinated convertible promissory notes (the "September 2024 Notes") as part of a private placement offering of up to $15.0 million in purchase price for such September 2024 Notes in the aggregate (the "Financing Closing"). The Company received $1.45 million in proceeds from the issuance of its convertible promissory notes. In addition to a September 2024 Note, each Investor received, as a transfer from NLabs Inc., an affiliated of Allen Salmasi, our Chief Executive Officer ("NLabs"), immediately prior to the Financing Closing, a number of shares of Private Veea's Series A-1 Preferred Stock that upon the Closing became a number of registered shares of Common Stock equal to such Investors' original principal note loan amount under their respective notes divided by $7.50 (the "Transferred Shares"). 2.0 million Transfer Shares were delivered to Investors at the Financing Closing. The Note Purchase Agreements include customary registration rights.

The Transferred Shares were recorded at a fair value of $21.6 million on the Company's consolidated financial statements at issuance, which reflected a significant discount to the face amount of the September 2024 Notes. In addition to the cash received at the Financing Closing, one of the Investors committed to purchase approximately $13.6 million (the "Commitment Amount") of September 2024 Notes, on or prior to November 15, 2024, which date was subsequently extended to December 15, 2024. On December 31, 2024, the Company and one of the Investors entered into a mutual Settlement and Release Agreement pursuant to which the Company agreed to terminate the Investor's obligation to purchase a note in the Commitment Amount and provided for a mutual release of claims, in exchange for a payment to the Company of an aggregate amount of approximately $5.4 million, which amount includes payments previously made to the Company in respect of the Commitment Amount. As the Company received approximately $1.5 million of the total expected $15.0 million proceeds at the Financing Closing, a proportional amount (approximately $19.5 million) of the substantial discount was deferred and recorded as a deferred financing asset on the Company's consolidated financial statements. At December 31, 2024, the deferred financing assets were reversed on the Company's consolidated financial statements.

The Company and VeeaSystems Inc. ("VeeaSystems") are co-borrowers under each September 2024 Note (together, the "Borrowers") and are jointly responsible for the obligations to each Investor thereunder. Each September 2024 Note has a maturity date of 18 months after the Financing Closing but is prepayable in whole or in part by the Borrowers at any time without penalty. The outstanding obligations under each September 2024 Note accrues interest at a rate equal to the Secured Overnight Financing Rate plus 2% per annum, adjusted quarterly, but interest is only payable upon the maturity date of the September 2024 Note as long as there is no event of default thereunder. Each September 2024 Note is unsecured and expressly subordinated to any senior debt of the Borrowers. The September 2024 Notes and the Note Purchase Agreements do not include any operational or financial covenants for the Borrowers. Each September 2024 Note includes customary events of default including, without limitation, failure to pay amounts due on the maturity date, failure to otherwise comply with the Borrowers' covenants or for Borrower insolvency events, in each case, with customary cure periods. Upon an event of default, the Investor may accelerate all obligations under its September 2024 Note and the Borrowers will be required to pay for the Investor's reasonable out-of-pocket collection costs.

The outstanding obligations under each September 2024 Note are convertible in whole or in part into shares of Common Stock (the "Conversion Shares") at a conversion price of $7.50 per share (subject to equitable adjustment for stock splits, stock dividends and the like with respect to the Common Stock after the Financing Closing) (the "Conversion Price") at any time after the Financing Closing at the sole election of the Investor. The outstanding obligations under each September 2024 Note will automatically convert at the Conversion Price if (i) the Company or its subsidiaries consummate one or more additional financings for equity or equity-linked securities for at least $20 million in the aggregate or makes one or more significant acquisitions valued in the aggregate (based on the consideration provided by the Company and its subsidiaries) to be at least $20 million, (ii) the Investors holding a majority of the aggregate outstanding obligations under the September 2024 Notes expressly agree to convert all obligations under the September 2024 Notes or (iii) the Common Stock trades with an average daily VWAP of at least $10.00 (subject to equitable adjustment for stock splits, stock dividends and the like with respect to the Common Stock after the Financing Closing) for ten (10) consecutive trading days. The obligations under each September 2024 Note will also automatically convert in connection with a Brokerage Transfer, as described below.

The Conversion Shares were initially subject to a lock-up for a period of 6 months after the Financing Closing. The Transferred Shares were not subject to any lock-up restrictions, but for a period of 6 months after the Closing they were separately designated by the Transfer Agent and kept as book entry shares on the Transfer Agent's records and were not be eligible to be held by DTC without the Investor first notifying the Company of its intent to transfer any such Transferred Shares to a brokerage account and/or to be held by DTC or another nominee (a "Brokerage Transfer"). If the Investor provided such notice or otherwise has any Transferred Shares subject to a Brokerage Transfer within 6 months after the Closing, a portion of the outstanding obligations under such Investor's Note would automatically convert into a number of Conversion Shares equal to the number of Transferred Shares subject to such Brokerage Transfer, and the lock-up period for such Conversion Shares would be extended for an additional 6 months to 12 months after the Financing Closing. As of September 30, 2025, $700,000 in aggregate principal amount of the September 2024 Notes, together with associated interest, had automatically converted upon the occurrence of a Brokerage Transfer.

The Company reviewed the conversion feature granted in the notes under ASC 815, "*Derivatives and Hedging*" ("ASC 815"), and concluded that the conversion price was based on a variable (enterprise value) that was not an input to the fair value of a "fixed-for-fixed" option as defined under ASC 815 - 40 and is therefore considered a conversion option liability that should be bifurcated from the debt host. As the fair value of the conversion option liability exceeded the net proceeds received, in accordance with ASC 470-20, the Company recorded the conversion option liability at fair value with the excess of the fair value over the net proceeds received recognized as a loss in earnings. See Note 15 for further information.

***Convertible Notes Payable Issued in connection with Crowdkeep Acquisition***

On April 17, 2025, and May 13, 2025, the Company and the majority stockholder of the Seller ("Crowdkeep Investor"), entered into two Note Purchase Agreements (the "Crowdkeep Note Purchase Agreements"). Pursuant to the Crowdkeep Note Purchase Agreements, the Crowdkeep Investor loaned to the Company an aggregate of $1,000,000 in two tranches (the "Crowdkeep Loans"), of which $500,000 was provided on April 17, 2025 and $500,000 was provided on May 13, 2025. In connection with the entry into the Crowdkeep Note Purchase Agreements the Company issued to the Crowdkeep Investor unsecured convertible promissory notes (the "Crowdkeep Convertible Notes"). The Crowdkeep Convertible Notes have an aggregate principal amount of $1,000,000, and the interest under the Crowdkeep Convertible Notes accrues at an annual rate of 8%. The maturity date of the Crowdkeep Convertible Notes are April 17, 2026, and May 13, 2026, respectively.

Pursuant to the terms of the Convertible Notes, upon an event of default, the outstanding principal amount of the applicable Crowdkeep Convertible Note, plus accrued but unpaid interest, will become immediately due and payable in full. Events of default include failure to pay any principal or interest amounts under the Crowdkeep Convertible Notes, failure to perform covenants in the Crowdkeep Convertible Notes and certain bankruptcy and insolvency conditions of the Company. The Company may prepay all or any portion of the Crowdkeep Convertible Notes at any time. The Crowdkeep Convertible Notes are convertible, in whole or in part, into shares of Common Stock (the "Crowdkeep Conversion Shares") at the option of the Crowdkeep Investor, at a price per share of $5.00 subject to certain equitable adjustments. The Crowdkeep Convertible Notes will automatically convert on the date that the closing price of the Common Stock is at $7.50 or above for ten (10) consecutive trading days within any consecutive thirty (30) trading day period, equal to the lesser of (i) $7.50 per share and (ii) 20% multiplied by the VWAP (calculated as set forth in the Crowdkeep Convertible Notes) for the prior consecutive thirty (30) trading day period, in each case subject to certain equitable adjustments. The Crowdkeep Note Purchase Agreements and Crowdkeep Convertible Notes include other customary terms and conditions.

**9 - INVESTMENTS**

The Company accounts for its private company investments without readily determinable fair values under the cost method. These investments, for which the Company is not able to exercise significant influence over any one individual investee, is measured and accounted for using an alternative measurement basis of a) the security's carrying value at cost, b) less any impairment and c) plus or minus any qualifying observable price changes. Observable price changes or impairments recognized on the Company's private company investments would be classified as a Level 3 financial instrument within the fair value hierarchy based on the nature of the fair value inputs. Any adjustments to the carrying values are recognized in other income, net in the Company's consolidated statements of operations and comprehensive loss. As of December 31, 2024, the Company performed the qualitative assessment for impairment of its investments. Based on this qualitative assessment, impairment indicators were present for one of its investments; therefore, the company performed an analysis to estimate its fair value and recognized an impairment loss of $216,278. As of September 30, 2025, there were no indicators of impairment. These investments, which do not have a stated contractual maturity date, were classified as Investments on the Company's consolidated balance sheets.

**10 - STOCKHOLDERS' EQUITY**

On September 13, 2024, the Company consummated the Business Combination which was accounted for as a reverse recapitalization. In connection with the consummation of the Business Combination (i) the Company de-registered from the Register of Companies in the Cayman Islands by way of continuation out of the Cayman Islands and into the State of Delaware, migrating to and domesticating as a Delaware corporation (the "Domestication") and (ii) restated our certificate of incorporation ("Restated Certificate of Incorporation"). In connection with the Domestication, each share of outstanding Class A ordinary shares were converted by operation of law into shares of Common Stock, on a one-for-one basis. Upon filing of the Restated Certificate of Incorporation, each issued and outstanding share of Class B stock outstanding immediately prior to the filing of the Restated Certificate of Incorporation was converted into shares of Common Stock on a one-for-one basis. Under the Restated Certificate of Incorporation, the Company is authorized to issue 551,000,000 shares of capital stock, consisting of (a) 550,000,000 shares of Common Stock with a par value of $0.0001 per share and (b) 1,000,000 shares of preferred stock with a par value of $0.0001 per share.

Holders of Common Stock are entitled vote on all matters submitted to the stockholders vote or approval, other than on any amendment to the Restated Certificate of Incorporation (including any certificate of designations relating to any series of Preferred Stock) that relates solely to the terms of one or more outstanding series of Preferred Stock if the holders of such affected series are entitled, either separately or together as a class with the holders of one or more other such series, to vote thereon pursuant to the Restated Certificate of Incorporation (including any certificate of designations relating to any series of Preferred Stock). Holders of Common Stock are entitled to one vote per share on all matters submitted to the stockholders for their vote or approval.

**Equity Line of Credit**

On December 2, 2024, the Company entered into a common stock purchase agreement ("Common Stock Purchase Agreement") and related registration rights agreement (the "Registration Rights Agreement") with White Lion Capital, LLC ("White Lion"). Pursuant to the Common Stock Purchase Agreement, the Company has the right, but not the obligation, to direct White Lion to purchase up to $25.0 million in aggregate gross purchase price of newly issued shares of Common Stock, subject to certain limitations and conditions as described below (the "ELOC Program"), at a purchase price equal to (i) 96.5% of the volume weighted average stock price for the three consecutive business days after a purchase notice is given, (ii) 98% of the volume weighted average stock price on the day a notice is delivered, or (iii) the lowest traded price for a given purchase date.

The Company controls the timing and amount of any sales to White Lion, which depend on a variety of factors including, among other things, market conditions, the trading price of the Common Stock, and determinations by the Company as to appropriate sources of funding for its business and operations. However, White Lion's obligation to purchase shares is subject to certain conditions, including the daily trading volume of the Company's stock. In all instances, the Company may not sell shares of Common Stock under the Purchase Agreement if it would result in White Lion and its affiliate beneficially owning more than 4.99% of its outstanding voting power or shares of the Common Stock at any one point in time, or the aggregate number of shares of common stock would not exceed 19.99% of the voting power of the issued and outstanding Common Stock.

The Company did not draw on the ELOC during the three months ended September 30, 2025, and received $836,766 in proceeds from draws on the ELOC during the nine months ended September 30, 2025, and issued 358,000 shares of Common Stock, pursuant to the ELOC Program.

The Company agreed to issue to White Lion shares of Common Stock as a commitment fee (the "Commitment Shares"). The fair value of the Commitment Shares was $25,000, which pursuant to ASC 815, was recorded in transaction costs in the condensed consolidated statement of operations and comprehensive income (loss) during the nine months ended September 30, 2025. The Common Stock Purchaser has agreed that during the term of the Common Stock Purchase Agreement, neither it nor any of its affiliates will engage in any short sales or hedging transactions involving the Common Stock. Further, the Common Stock Purchase Agreement provided for the issuance of additional Commitment Shares to the Common Stock Purchaser if the Company failed to sell at least $1,000,000 in gross proceeds to the Common Stock Purchaser by the sixth-month anniversary of signing of the Common Stock Purchase Agreement. The Company and the Common Stock Purchaser amended the Common Stock Purchase Agreement effective of June 2, 2025 (the "ELOC Amendment") to provide for (i) an extension of the time period to December 15, 2025 and (ii) an increase the gross proceeds sold under the Common Stock Purchase Agreement to $1,250,000. If the Company fails to sell such amount of, the number of additional Commitment Shares would be equal to $50,000 divided by the volume weighted average stock price of the Common Stock 10 days prior to December 15, 2025.

**August 2025 Public Offering**

On August 14, 2025, the Company closed a public offering (the "August 2025 Public Offering") of 9,189,096 shares of its common stock and warrants to purchase up to 9,189,096 shares of common stock (the "2025 Investor Warrants") at a combined offering price of $1.00 per share and accompanying warrant. The Company received aggregate cash gross proceeds of approximately $6.0 million, before deducting placement agent fees and other offering expenses. The 2025 Investor Warrants have an exercise price of $1.10 per share, are exercisable immediately, and will expire five years from the original issuance date. Included in the aggregate securities issued are 3,239,096 shares of common stock and accompanying warrants that were issued to NLabs in consideration and satisfaction of the NLabs 2025 Notes and associated interest. The Company is using the net proceeds from the Offering for investments in inventory and the Company's customer support infrastructure and for other working capital and general corporate purposes.

**11 - STOCK INCENTIVE PLANS**

In September 2014, the Private Veea's Board of Directors adopted the Max2 Inc. Equity Incentive Plan ("2014 Plan"). Upon adoption of the 2014 Plan, the aggregate number of shares of Common Stock reserved for awards under the Plan were 1,250,000. In September 2018, Private Veea's Board of Directors adopted the Veea Inc. 2018 Equity Incentive Plan ("2018 Plan" and collectively with the 2014 Plan, the "Private Veea Plans"). Upon adoption of the 2018 Plan, 4,900,000 shares of the Common Stock were reserved for the issuance of incentive awards. In January 2021, the 2018 Plan was amended to increase the total number of authorized shares reserved for issuance to 12,492,910. Under the Private Veea Plans, option awards were generally granted with an exercise price equal to the fair market value of the Company's stock at the date of grant; those option awards generally vested with a range of one to four years of continuous service and had ten-year contractual terms. Certain option awards provided for accelerated vesting if there was a change in control, as defined in the Private Veea Plans. The Private Veea Plans also permitted the granting of restricted stock and other stock-based awards. Unexercised options were cancelled upon termination of employment and became available for reissuance under the Private Veea Plans.

On June 4, 2024, the stockholders of the Company approved the Veea Inc. 2024 Incentive Award Plan (the "2024 Incentive Plan", collectively with the Private Veea Plans, the "Plans"), which became effective upon the Closing. The Company initially reserved 4,460,437 shares of Common Stock for the issuance of awards under the 2024 Incentive Plan ("Initial Limit"). The Initial Limit represented 10% of the aggregate number of shares of the Common Stock outstanding immediately after the Closing plus the number of shares of Common Stock issuable under the 2014 Plan and the 2016 Plan and is subject to increase each year over a ten-year period. The 2024 Incentive Plan provides for the grant of stock options, which may be ISOs or non-statutory stock options ("NSOs"), stock appreciation rights ("SARs"), restricted shares, restricted stock units ("RSUs") and other stock or cash-based awards that the Administrator determines are consistent with the purpose of the 2024 Incentive Plan. As of September 30, 2025, the Company had 464,776 shares available for grant.

On June 4, 2024, the stockholders of the Company approved Veea Inc. 2024 Employee Stock Purchase Plan (the "ESPP"), which became effective upon the Closing. An aggregate of 1,070,603 shares of Common Stock has been reserved for issuance or transfer pursuant to rights granted under the ESPP ("Aggregate Number"). The Aggregate Number represented 3% of the aggregate number of shares of Common Stock outstanding immediately after the Closing and is subject to increase each year over a ten-year period. The ESPP provides eligible employees with an opportunity to purchase Common Stock from the Company at a discount through accumulated payroll deductions. The ESPP will be implemented through a series of offerings of purchase rights to eligible employees. Under the ESPP, the Company's Board of Directors may specify offerings but generally provides for a duration of 12 months. The purchase price will be specified pursuant to the offering, but cannot, under the terms of the ESPP, be less than 85% of the lower of the fair market value per share of the Common Stock on either the offering date or on the purchase date. As of September 30, 2025, there have not yet been any offering periods available to purchase Common Stock under the ESPP.

In connection with the Business Combination, each Private Veea option that was outstanding immediate prior to Closing, whether vested or unvested, was exchanged for a stock option under the 2024 Plan (each an "Exchanged Option") to acquire a number of shares of Common Stock equal to the product of (i) the number of shares of Private Veea's common stock subject to such Private Veea option immediately prior to the Business Combination and (ii) the Exchange Ratio, at an exercise price per share equal to (A) the exercise price per share of such Private Veea option immediately prior to the consummation of the Business Combination, divided by (B) the Exchange Ratio. Following the Business Combination, each Exchanged Option continues to be governed by the same terms and conditions (including vesting and exercisability terms) as were applicable to the corresponding former Private Veea option immediately prior to the consummation of the Business Combination. Unvested Private Veea options did not accelerate nor vest on the consummation of the Business Combination. All stock option activity was retroactively restated to reflect the effect of the Exchange Ratio. Generally, stock options vest 25% on the first anniversary of the vesting commencement date and then quarterly thereafter for 12 quarters, or pursuant to another vesting schedule as approved by the Board and set forth in the option agreement. Stock options have a maximum term of ten years from the date of grant. The aggregate intrinsic value is the fair market value on the reporting date less the exercise price for each option. The fair value of each stock option award is estimated on the date of the grant using the Black-Scholes option-pricing model. For options granted during the nine months ended September 30, 2025 and 2024, respectively, the weighted average estimated fair value using the Black-Scholes option pricing model was $0.81 and $1.49 per option, respectively.

***Stock Options***

Stock option activity under the Plan was as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **Number of<br> Options** | **Weighted-<br> Average <br> Exercise<br> Price <br> per Share** | **Weighted-<br> Average <br> Remaining <br> Contractual<br> Term <br> (years)** |
| Outstanding at December 31, 2024 | 3790702 | $1.04 | 5.98 |
| Granted | 2596137 | 0.66 |  |
| Exercised | (15006) | - |  |
| Forfeited / Expired | (140307) | 2.64 |  |
| Outstanding at September 30, 2025 | 6231526 | 2.47 | 9.03 |
| Exercisable at September 30, 2025 | 3766429 | $3.64 | 8.45 |

---

On September 29, 2025, the compensation committee of the Board of Directors approved equity awards to certain Named Executive Officers ("NEO"), employees, and consultants in the form of options to purchase 2,375,000 shares of the Company's common stock (the "September 2025 Grants"), subject to (i) with respect to September 2025 Grants to the NEOs and other officers of the Company, to the Company's performance and time vesting schedules and (ii) with respect to September 2025 Grant to non-NEO officer employees and consultants, time vesting schedules. In addition, no portion of the September 2025 Grants may be exercised unless both (A) the Company's stockholders approve the September 2025 Grants or approval of an amendment to increase the number of shares under the 2024 Plan to a sufficient number of shares such that the full number of shares underlying the September 2025 Grants may be delivered from the Plan's share reserve and (B) the Company files a Form S-8 with the SEC to register the shares subject to the September 2025 Grants, and if either (A) or (B) is not satisfied, the September 2025 Grants may be fully unwound and cancelled.

The fair value of each stock option granted is estimated using the Black-Scholes option-pricing model using the single-option award approach. The range of weighted average assumptions used to calculate the fair value of the options granted during the nine months ended September 30, 2025, were as follows:

---

| | |
|:---|:---|
|  | **September 30,<br> 2025** |
| Stock Price | $0.66-1.34 |
| Expected term (years) | 4.2-5.0 |
| Volatility | 75% |
| Risk-Free Rate | 3.74-3.84% |

---

Stock compensation expense related to the common stock options outstanding for the nine months ended September 30, 2025 and 2024, was $203,616 and $394,234, respectively, which is included in general and administrative expenses in the Company's condensed consolidated statements of operations and comprehensive income (loss). Total unrecognized expense related to unvested options outstanding as of September 30, 2025, was $1,082,949, which will be recognized over a weighted average period of 3.9 years.

***Restricted Stock Units***

RSU activity under the Plan was as follows:

---

| | | |
|:---|:---|:---|
|  | **Number of<br> RSUs** | **Weighted-<br> Average <br> Grant Date <br> Fair Value** |
| Unvested at December 31, 2024 | - | $&nbsp;&nbsp;&nbsp;&nbsp; - |
| Granted | 695034 | 1.60 |
| Vested | (91.454) | 1.60 |
| Forfeited | (3580) | 1.60 |
| Unvested at September 30, 2025 | 600000 | $1.60 |

---

Stock compensation expense related to the RSUs for the nine months ended September 30, 2025 was $555,507 which is included in general and administrative expenses in the Company's condensed consolidated statements of operations and comprehensive loss. There were no RSUs granted during the nine months ended September 30, 2024. Total unrecognized expense related to unvested RSUs as of September 30, 2025, was $550,820 which will be recognized over a weighted average period of 0.58 years.

**12 - WARRANTS**

**Public Warrants**

As part of Plum's initial public offering ("IPO"), Plum issued warrants to third-party investors where each whole warrant entitles the holder to purchase one share of the Common Stock at an exercise price of $11.50 per share (the "Public Warrants"). Simultaneously with the closing of the IPO, Plum completed the private sale of warrants (the "SPAC Private Placement Warrants" and together with the Public Warrants, the "SPAC Warrants") where each Private Placement Warrant allows the holder to purchase one share of the Common Stock at $11.50 per share. At September 30, 2025, there were 6,384,326 Public Warrants and 5,256,218 SPAC Private Placement Warrants outstanding.

The Public Warrants are exercisable at per share, subject to adjustment, provided that the Company has an effective registration statement under the Securities Act covering the shares of Common Stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement) and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder. The warrants will expire five years after the completion of the Business Combination or earlier upon redemption or liquidation.

The Company filed with the SEC a registration statement for the registration, under the Securities Act, of the shares of Common Stock issuable upon exercise of the SPAC Private Placement Warrants. Such registration statement was declared effective by the SEC on January 15, 2025.

With the exception of the SPAC Private Placement Warrants, in no event will the Company be required to net cash settle any warrant. In the event that a registration statement is not effective for the exercised warrants, the purchaser of a unit containing such warrant will have paid the full purchase price for the unit solely for the shares of Common Stock underlying such Warrant.

**Redemption of SPAC Warrants When the Price per Share of Common Stock Equals or Exceeds $18.00**

Once the SPAC Warrants become exercisable, the Company may redeem the outstanding Warrants (except with respect to the SPAC Private Placement Warrants):

● in whole and not in part;

● at a price of $0.01 per warrant;

● upon not less than 30 days' prior written notice of redemption to each warrant holder; and

● if, and only if, the last reported sale price of our Common Stock equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant) for any 20 trading days within a 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders.

**Redemption of SPAC Warrants When the Price per Share of Common Stock Equals or Exceeds $10.00**

Once the SPAC Warrants become exercisable, the Company may redeem the outstanding SPAC Warrants:

● in whole and not in part;

● at $0.10 per warrant upon a minimum of 30 days' prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares, based on the redemption date and the "fair market value" (as defined above) of our Common Stock;

● if, and only if, the closing price of our Common Stock equals or exceeds $10.00 per public share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant) for any 20 trading days within the 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and

● if the closing price of our Common Stock for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant), the SPAC Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above.

The SPAC Private Placement Warrants were initially issued in the same form as the Public Warrants with the exception that the SPAC Private Placement Warrants: (i) would not be redeemable by the Company and (ii) may be exercised for cash or on a cashless baseless so long as they are held by the initial purchasers or their permitted transferees, the SPAC Private Placement Warrants will be redeemable by the Company and exercisable by the holders on the same basis as the Public Warrants.

The Public Warrants were initially classified as a derivative liability instrument. Upon the closing of the Business Combination, the Public Warrants in accordance with the guidance contained in ASC 815 are no longer precluded from equity classification. Equity-classified contracts are initially measured at fair value (or allocated value). Subsequent changes in fair value are not recognized as long as the contracts continue to be classified in equity.

The Company continues to recognize the SPAC Private Placement Warrants as liabilities at fair value as of the Closing Date, with an offsetting entry to additional paid-in capital and adjusts the carrying value of the instruments to fair value through other income (expense) on the condensed consolidated statement of operations and comprehensive income (loss) at each reporting period until they are exercised. As of September 30, 2025, the SPAC Private Placement Warrants are presented within warrant liabilities on the condensed consolidated balance sheet.

*Private Veea Warrants* 

Upon the closing of the Business Combination, the Related Party Common Stock Warrants were exercised in whole, on a net basis, for 3,880,000 shares of common stock of Private Veea at a conversion price of $0.01 per share for an aggregate purchase price of $38,800. A total of 21,798 shares of common stock were surrendered in payment of the purchase price.

In connection with the Business Combination, Private Veea's outstanding equity-classified Preferred stock warrants were exchanged for common stock warrants of the Company (each an "Exchanged Warrant") to purchase a number of shares of Common Stock, after adjustment for anti-dilutive shares, equal to the product of (i) the number of shares of Private Veea's common stock subject to such Preferred Stock warrant immediately prior to the Business Combination and (ii) the Exchange Ratio, at an exercise price per share equal to (A) the exercise price per share of such Preferred Stock warrant immediately prior to the consummation of the Business Combination, divided by (B) the Exchange Ratio. On November 6, 2024, the warrant holder exercised warrants to purchase 79,654 shares of Common Stock at an exercise price of $0.05 per share for an aggregate purchase price of $3,983. The outstanding Exchanged Warrants are exercisable at the option of the holder until September 28, 2028, for an exercise price of $10.19 per share. As of September 30, 2025, there are 159,307 Exchanged Warrants outstanding.

**2025 Investor Warrants**

In connection with the August 2025 Public Offering, the Company issued the warrants to purchase up to 9,189,096 shares of common stock investors (the "2025 Investor Warrants"), including related parties. Each 2025 Investor Warrant entitles the holder to purchase one share of the Common Stock at an exercise price of $1.10. The exercise price is subject to appropriate adjustment in the event of certain stock dividends and distributions, stock splits, stock combinations, reclassifications or similar events affecting our common stock and also upon any distributions of assets, including cash, stock or other property to our stockholders. No fractional shares of common stock will be issued in connection with the exercise of the warrant. In lieu of fractional shares, the Company will pay the holder an amount in cash equal to the fractional amount multiplied by the exercise price. The 2025 Investor Warrants will expire five years from their issuance date. The 2025 Investor Warrants have not been listed on Nasdaq or any other national securities exchange or other nationally recognized trading system.

Each 2025 Investor Warrant is exercisable, at the option of the holder thereof, in whole or in part, by delivering to a duly executed exercise notice accompanied by payment in full in immediately available funds for the number of shares of our common stock purchased upon such exercise (except in the case of a cashless exercise as described below).

A holder (together with its affiliates) may not exercise any portion of the 2025 Investor Warrant to the extent that the holder would own more than 4.99% (or, at the election of the holder, 9.99)% of the outstanding common stock immediately after exercise, except that upon at least 61 days' prior notice from the holder to the Company, the holder may increase the amount of ownership of outstanding stock after exercising the holder's 2025 Investor Warrants up to 9.99% of the number of shares of our common stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the 2025 Investor Warrants.

If the holder of 2025 Investor Warrants exercises its warrants and a registration statement registering the issuance of the shares of common stock underlying the warrants under the Securities Act is not then effective or available (or a prospectus is not available for the resale of shares of common stock underlying the warrants), then in lieu of making the cash payment otherwise contemplated to be made to the Company upon such exercise in payment of the aggregate exercise price, the holder shall instead receive upon such exercise (either in whole or in part) only the net number of shares of common stock determined according to a formula set forth in the common warrants. Notwithstanding anything to the contrary, in the event the Company does not have or maintain an effective registration statement, there are no circumstances that would require the Company to make any cash payments or net cash settle the common warrants to the holders.

Subject to applicable laws, the 2025 Investor Warrants may be offered for sale, sold, transferred or assigned at the option of the holder upon surrender of such holder's warrants to the Company together with the appropriate instruments of transfer.

In the event of a fundamental transaction, as described in the 2025 Investor Warrants and generally including any reorganization, recapitalization or reclassification of our common stock, the sale, transfer or other disposition, in each case, of all or substantially all of our properties or assets, our consolidation or merger with or into another person, the acquisition of more than 50% of our outstanding common stock, or any person or group becoming the beneficial owner of 50% of the voting power represented by our outstanding common stock, the holders of the common warrants will be entitled to receive upon exercise of the common warrants the kind and amount of securities, cash or other property that the holders would have received had they exercised the warrants immediately prior to such fundamental transaction. In the case of certain fundamental transactions affecting us, a holder of the 2025 Investor Warrants, upon exercise of such warrants after such fundamental transaction, will have the right to receive, in lieu of shares of our common stock, the same amount and kind of securities, cash or property that such holder would have been entitled to receive upon the occurrence of the fundamental transaction, had the warrants been exercised immediately prior to such fundamental transaction.

The Company recognized the 2025 Investor Warrants as liability-classified at fair value as of the closing date, with an offsetting entry to additional paid-in capital and adjusts the carrying value to fair value through other income (expense) on the condensed consolidated statement of operations and comprehensive income (loss) at each reporting period until they are exercised. As of September 30, 2025, the 2025 Investor Warrants are presented within warrant liability on the condensed consolidated balance sheet.

**13 - RELATED PARTY TRANSACTIONS**

**Lease Agreements**

On March 1, 2014, Private Veea entered into a sublease agreement with NLabs Inc., an affiliate of the Company's CEO that held approximately 35% of the Company's outstanding capital stock at September 30, 2025, for office space for an initial term of five years. In 2018, Private Veea renewed the sublease for an additional five-year term, with all other terms and conditions of the sublease remaining the same. The renewal term expired February 28, 2024, and was subsequently extended to December 31, 2025. Rent for the office space is accrued and not paid in cash. The Company recognized rent expense of $61,200 and $183,600 for each of the three and nine months ended September 30, 2025 and 2024, respectively, which was classified as general and administrative expenses in the Company's condensed consolidated statements of operations and comprehensive income (loss). Accrued and unpaid rent expense included in the Company's condensed consolidated balance sheets was $1,897,200 as of September 30, 2025 and $1,713,600 as of December 31, 2024.

In April 2017, Private Veea entered into a lease agreement with 83<sup>rd</sup> Street LLC to lease office space for an initial term of two years. The sole member of 83<sup>rd</sup> Street LLC is the Salmasi 2004 Trust. At December 31, 2024, the Salmasi 2004 Trust held approximately 8% of Veea's outstanding capital stock. Veea's CEO is the grantor of the Salmasi 2004 Trust. In 2018, Private Veea renewed the lease for an additional five-year term, with all other terms and conditions of the lease remaining the same. The renewal term expired February 28, 2024, and was subsequently extended to December 31, 2025. Rent for the office space is accrued and not paid in cash. The Company recognized rent expense of $72,000 and $532,800 for each of the three and nine months ended September 30, 2025 and 2024, respectively, which is classified as general and administrative expenses in the Company's condensed consolidated statements of operations and comprehensive income (loss). Accrued and unpaid rent expense included in the Company's condensed consolidated balance sheets was $2,160,000 and $1,944,000 as of September 30, 2025 and December 31, 2024, respectively.

**Related Party Debt**

At the Closing of the Business Combination, promissory notes evidencing loans made by NLabs to the Company from 2021 through the Closing (the "Related Party Notes") in the aggregate amount, including accrued interest, of $15,739,897, were converted into shares of Common Stock at a price of $5.00 per share, which shares were not considered Existing Veea Shares and were in addition to the shares of Common Stock issued to holders of Existing Veea Shares. See Note 4 for further information regarding the conversion of the Related Party Notes.

During the nine months ended September 30, 2025, NLabs made loans to the Company in the aggregate principal amount of $3,176,000 (the "NLabs 2025 Notes"). Interest on the loans accrued at a rate of 10% per annum, calculated on the basis of a 365-day year. The Company satisfied the payment of the outstanding NLabs 2025 Notes, plus accrued interest, in the aggregate amount of $3,239,096, with the issuance of 3,239,096 shares of Common Stock with accompanying common warrants issued in the August 2025 Public Offering, based on the offering price of $1.00 per share.

In October and November 2025, NLabs made additional loans to the Company in the aggregate principal amount of $130,000 pursuant to certain promissory notes. Interest on the NLabs promissory notes accrue at a rate of 10% per annum, calculated on the basis of a 365-day year. Principal and accrued interest is payable upon the earlier of on demand and March 31, 2026.

**14 - COMMITMENTS AND CONTINGENCIES**

**Purchase Commitments with Contract Manufacturers and Suppliers**

As of September 30, 2025, the Company had no unconditional purchase obligations for the purchase of goods or services from suppliers and contract manufacturers. Unconditional purchase obligations are obligations that are enforceable and legally binding on the Company and specify all significant terms, including quantities to be purchased, fixed, minimum or variable price provisions and the approximate timing of the transaction. Unconditional purchase obligations exclude agreements that are cancellable without penalty.

**Leases**

The Company leases office space in the U.S., including office space from related parties as disclosed in Note 13. Under the terms of the various lease agreements, the Company may bear certain costs such as maintenance, insurance and taxes. Lease agreements may provide for increasing rental payments at fixed intervals. The Company's CEO has guaranteed the obligations under the office space leased in New Jersey. The Company also leases offices in the United Kingdom, France, and Mexico under short-term arrangements of twelve months or less.

**Indemnifications**

In the normal course of business, the Company has indemnification obligations to other parties, including customers, lessors, and parties to other transactions with us, with respect to certain matters. The Company has agreed to indemnify against losses arising from a breach of representations or covenants or out of intellectual property infringement or other claims made against certain parties. These agreements may limit the time or circumstances within which an indemnification claim can be made and the amount of the claim.

It is not possible to determine the maximum potential amount for claims made under the indemnification obligations due to uncertainties in the litigation process, coordination with and contributions by other parties and the defendants in these types of cases, and the unique facts and circumstances involved in each particular case and agreement. To date, the Company has made no indemnity payments. In addition, the Company has entered into indemnification agreements with its officers and directors, and its Amended and Restated Bylaws contain similar indemnification obligations to its agents.

**Litigation**

In the normal course of business, the Company may become involved in various lawsuits and legal proceedings. The Company accrues contingent liabilities when it is probable that future expenditures will be made, and such expenditures can be reasonably estimated. While the ultimate results of these matters cannot be predicted with certainty, management does not expect them to have a material adverse effect on the financial position or results of operations of the Company.

**Other Commitments**

In connection with the Business Combination, the Company agreed to pay certain legal expenses contingent upon the closing of the Business Combination, certain of which expenses were mutually agreed to be deferred to periods after the Closing. As of September 30, 2025, the amount of the deferred fees totaled $2,257,457, recorded in deferred payables, current in the condensed consolidated balance sheet.

**15 - FAIR VALUE MEASUREMENTS**

**Recurring Fair Value Measurements**

 ****

The following table presents fair value information as of September 30, 2025 and December 31, 2024, of the Company's financial assets and liabilities that were accounted for at fair value on a recurring basis and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. During the nine months ended September 30, 2025, there were no transfers amongst level 1, 2, and 3 values during the period.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **September 30, 2025** | **Total** | **Level 1** | **Level 2** | **Level 3** |
| SPAC Private Placement Warrant liability | $367935 |  | $367935 | $&nbsp;&nbsp;&nbsp;&nbsp;- |
| 2025 Investor Warrant liability | 2958889 |  |  | 2958889 |
| Convertible note option liability | - |  | - | - |
| Earn-out share liability | 2040000 |  | - | 2040000 |
| Total | $5366824 |  | $367935 | $4998889 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **December 31, 2024** | **Total** | **Level 1** | **Level 2** | **Level 3** |
| SPAC Private Placement Warrant liability | $840994 |  | $840994 | $- |
| Convertible note option liability | 60000 |  | - | 60000 |
| Earn-out Share Liability | 15560000 |  | - | 15560000 |
| Total | $16460994 |  | $840994 | $15620000 |

---

*Warrant Liabilities*

The Company's initial value of the SPAC Private Placement Warrant liability as of September 13, 2024, was based on a valuation model utilizing management judgment and pricing inputs from observable and unobservable markets with less volume and transaction frequency than active markets and was classified as level 3. The subsequent measurement of the SPAC Private Placement Warrants is classified as Level 2 because these warrants are economically equivalent to the Public Warrants, based on the terms of the SPAC Private Placement Warrant agreement, and as such their value is principally derived by the value of the Public Warrants. Significant deviations from these estimates and inputs could result in a material change in fair value.

*2025 Investor Warrants*

 

The Company established the initial fair value of the 2025 Investor Warrants liability as of August 14, 2025, the date of the August 2025 Public Offering. As of September 30, 2025, the fair value was remeasured using an option pricing model. The option pricing model was used to value the liability for the initial period and subsequent measurement periods.

The 2025 Investor Warrant liability was classified within Level 3 of the fair value hierarchy due to the use of unobservable inputs. The key inputs into the option pricing model were as follows at August 14, 2025 initial value, and at September 30, 2025:

---

| | | |
|:---|:---|:---|
|  | **September 30, <br> 2025** | **August 14, 2025** |
| Stock Price | $0.62 | $0.60 |
| Expected term (years) | 4.9 | 5.0 |
| Volatility | 75.0% | 75.0% |
| Risk-Free Rate | 4.20% | 4.16% |

---

---

| | |
|:---|:---|
|  | **Nine Months<br> Ended<br> September 30, <br> 2025** |
| Balance, beginning of period | $- |
| Initial value, August 14, 2025 | 3130352 |
| Change in fair value | (171463) |
| Balance, end of period | $2958889 |

---

*Convertible Note Option Liability*

The Company established the initial fair value for the convertible note option liability as of September 13, 2024, which was the date the Convertible Note was executed. As of September 30, 2025, the fair value was remeasured using an option pricing model. The option pricing model was used to value the convertible note option liability for the initial periods and subsequent measurement periods.

The conversion feature of the Convertible Promissory Notes is measured at fair value using a Monte Carlo model that fair values the conversion option.

The convertible note option liability was classified within Level 3 of the fair value hierarchy due to the use of unobservable inputs. The key inputs into the option pricing model for the convertible note option liability were as follows:

---

| | | |
|:---|:---|:---|
|  | **September 30, <br> 2025** | **December 31,<br> 2024** |
| Stock Price | $1.83 | $3.81 |
| Expected term (years) | 0.45 | 1.2 |
| Volatility | 75.0% | 75.0% |
| Risk-Free Rate | 4.16% | 4.18% |
| Interest rate | 6.24% | 6.49% |

---

---

| | |
|:---|:---|
|  | **Nine Months<br> Ended<br> September 30, <br> 2025** |
| Balance, beginning of period, December 31, 2024 | $60000 |
| Change in fair value | (60000) |
| Balance, end of period | $- |

---

*Earn-out Share Liability*

Following the closing of the Business Combination, holders of certain capital stock of Private Veea immediately prior to the closing have the contingent right to receive up to 4.5 million additional shares of Common Stock if certain trading-price based milestones of the Common Stock are achieved or a change of control transaction occurs during the ten-year period following the Closing. The Company's obligation to issue the earn out shares is recorded as a contingent liability (the "Earn-out Share Liability") in the Company's financial statements. The initial value of the contingent Earn-out Share Liability of $53.6 million was recorded as a transaction cost within operating expenses. The fair value of the Earn-out Share Liability was estimated using a Monte Carlo simulation utilizing assumptions related to the contractual term of the instruments, estimated volatility, the price of the Common Stock, and current interest rates.

The following table presents the changes in fair value of the Earn-Out Share Liability:

---

| | |
|:---|:---|
|  | **Nine Months<br> Ended <br> September 30,<br> 2025** |
| Balance, beginning of period, December 31, 2024 | $15560000 |
| Change in fair value | 13520000 |
| Balance, end of period | $2040000 |

---

The key inputs for the Earn-out Share Liability were as follows:

---

| | | |
|:---|:---|:---|
|  | **September 30, <br> 2025** | **December 31,<br> 2024** |
| Stock Price | $0.62 | $6.5 |
| Expected term (years) | 9 | 10 |
| Volatility | 80.0% | 75.0% |
| Risk-Free Rate | 4.18% | 3.81% |

---

**16 - EARNINGS PER SHARE**

The computation of basic and dilutive net loss per share attributable to common stockholders for the nine months ended September 30, 2025 and 2024, are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended<br> September 30,** | **Three Months Ended<br> September 30,** | **Nine Months Ended<br> September 30,** | **Nine Months Ended<br> September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| **Basic:** |  |  |  |  |
| Numerator: |  |  |  |  |
| Net income (loss) attributable to common shareholders | $1375294 | $(33323555) | $(1736512) | $(46620619) |
| Denominator: |  |  |  |  |
| Weighted-average common shares outstanding | 45644909 | 22292374 | 40325293 | 20217081 |
| **Net income (loss) per share – basic:** | $0.03 | $(1.49) | $(0.04) | $(2.31) |
| **Diluted:** |  |  |  |  |
| Numerator: |  |  |  |  |
| Net income (loss) attributable to common and common equivalent shareholders | 1375294 | (33323555) | (1736512) | (46620619) |
| Denominator: |  |  |  |  |
| Weighted-average common stock outstanding | 45, 644909 | 22292374 | 40, 325293 | 20217081 |
| Stock options, RSUs, warrants, Earn-Out Liability, and convertible notes outstanding to purchase shares of common stock | 25487 | - | - | - |
| Total common and common equivalent shares outstanding | 45670396 | 22292374 | 40, 325293 | 20217081 |
| **Net income (loss) per share – diluted:** | $0.03 | $(1.49) | $(0.04) | $(2.31) |

---

The weighted average potential shares of common stock that were excluded from the calculation of net income (loss) per share-diluted for the periods presented because including them would have been anti-dilutive consisted of the following:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended <br> September 30,** | **Three Months Ended <br> September 30,** | **Nine Months Ended<br> September 30,** | **Nine Months Ended<br> September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Stock options outstanding to purchase shares of common stock and RSUs | 4453687 | - | 4299474 | - |
| Public Warrants | 6384326 | 1179712 | 6384326 | 397559 |
| SPAC Private Placement Warrants | 5256218 | 971258 | 5256218 | 327310 |
| Private Veea Warrants | 159307 | 29437 | 159307 | 9920 |
| 2025 Investor Warrants | 4694429 | - | 1582006 | - |
| Convertible Notes | 233333 | 193333 | 139288 | 64.444 |

---

The weighted average potential shares of common stock that were excluded from the calculation of net income (loss) per share-diluted because the performance or market conditions associated with these awards were not met are as follows for the periods presented:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended <br> September 30,** | **Three Months Ended <br> September 30,** | **Nine Months Ended<br> September 30,** | **Nine Months Ended<br> September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Earn-Out Liability | 4500000 |  | 4500000 |  |

---

**17 - EMPLOYEE 401(k) PLAN**

The Company sponsors a 401(k) plan (the "Plan") to provide retirement benefits for its employees.

As allowed under Section 401(k) of the Internal Revenue Code, the Plan provides for tax-deferred salary contributions and after-tax contributions for eligible employees. The Plan provides for tax-deferred salary contributions and after-tax contributions for eligible employees. Employee contributions are limited to a maximum annual amount as set periodically by the Internal Revenue Code. The Company matches pretax and Roth employee contributions up to 4% of eligible earnings that are contributed by employees. All matching contributions vest immediately. The Company's matching contributions to the Plan for the nine months ended September 30, 2025 and 2024, totaled $73,899 and $116,879, respectively. A total of $237,997 is reflected in accrued expenses in the condensed consolidated balance sheet for matching contributions accrued but not yet paid.

**18 - SUBSEQUENT EVENTS**

The Company evaluated subsequent events from September 30, 2025, the date of these financial statements, through the date on which the financial statements were issued (the "Issuance Date"), for events requiring recording or disclosure in the financial statements as of and for the nine months ended September 30, 2025. The Company concluded that no events have occurred that would require recognition or disclosure in the financial statements.

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations**

*The following discussion and analysis of the financial condition and results of operations of Veea should be read together with our audited consolidated financial statements and unaudited consolidated condensed financial statements. In addition to our historical consolidated financial information, this discussion includes forward-looking information regarding our business, results of operations and cash flows, and contractual obligations and arrangements that involve risks, uncertainties, and assumptions. Our actual results may differ materially from any future results expressed or implied by such forward-looking statements as a result of various factors, including, but not limited to, those discussed in the Company's most recent Annual Report on Form 10-K filed with the SEC on April 15, 2025 (the "2024 10-K").*

*Unless the context otherwise requires, references in this "Management's Discussion and Analysis of Financial Condition and Results of Operations" to "Veea," "we", "us", "our", and the "Company" are intended to refer to (i) following the Business Combination, the business and operations of Veea Inc. and its consolidated subsidiaries, and (ii) prior to the Business Combination, Private Veea (the predecessor entity in existence prior to the consummation of the Business Combination) and its consolidated subsidiaries.*

Throughout this report, the terms "our," "we," "us," "Veea" and the "Company" refer to Veea Inc.

**CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS**

This Quarterly Report on Form 10-Q contains forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995, including statements regarding, among other things, the plans, strategies and prospects, both business and financial, of the Company. These statements are based on the beliefs and assumptions, whether or not identified in this Quarterly Report, of the management of the Company. Although the Company believes that its plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, the Company cannot assure you that it will achieve or realize these plans, intentions or expectations. Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Generally, statements that are not historical facts, including statements concerning possible or assumed future actions, business strategies, events or results of operations, and any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. These statements may be preceded by, followed by or include the words "anticipate," "believe," "could," "continue," "estimate," "expect," "forecast," "intend," "may," "might," "plan," "possible," "potential," "project," "scheduled," "seek," "should," "will" or similar expressions, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements contained in this Quarterly Report include, but are not limited to, statements about the ability of the Company to:

● failure to maintain adequate operational and financial resources or raise additional capital or generate sufficient cash flows;

● risks related to its current growth strategy and the Company's ability to generate revenue and become profitable;

● market acceptance of its platform and products;

● the length and unpredictable nature of its sales cycles;

● Veea's reliance on distribution and partnering arrangements and third-party manufacturers;

● cybersecurity incidents, security vulnerabilities, and real or perceived errors, failures, defects, or bugs in its platforms or products;

● the ability to maintain the listing of our common stock and public warrants on Nasdaq, and the potential liquidity and trading of such securities;

● our public securities' potential liquidity and trading;

● our success in retaining or recruiting, or changes required in, our officers, key employees or directors, and our ability to attract and retain key personnel;

● macroeconomic conditions; and

● each of the other factors detailed under the section entitled "*Risk Factors*."

Forward-looking statements are provided for illustrative purposes only and are not guarantees of performance. You should not put undue reliance on these statements which speak only as of the date hereof. You should understand that the factors discussed under the heading "*Risk Factors*" and elsewhere in this Quarterly Report and as disclosed on the 2024 10-K, could affect the future results of the Company, and could cause those results or other outcomes to differ materially from those expressed or implied in the forward-looking statements in this Quarterly Report.

In addition, the risks described under the heading "*Risk Factors*" in this Quarterly Report are not exhaustive. Other sections of this Quarterly Report describe additional factors that could adversely affect the businesses, financial conditions, or results of operations of the Company. New risk factors emerge from time to time and it is not possible to predict all such risk factors, nor can the Company assess the impact of all such risk factors on the business of the Company, or the extent to which any factor or combination of factors may cause actual results to differ materially from those contained in any forward-looking statements. All forward-looking statements attributable to the Company or persons acting on their behalf are expressly qualified in their entirety by the foregoing cautionary statements. The Company undertakes no obligations to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

In addition, this Quarterly Report contains statements of belief and similar statements that reflect the beliefs and opinions of the Company on the relevant subject. These statements are based upon information available to the Company as of the date of this Quarterly Report, and while the Company believes such information forms a reasonable basis for such statements, such information may be limited or incomplete, and statements should not be read to indicate that the Company has conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain, and you are cautioned not to unduly rely upon these statements

**Company Overview**

We are dedicated to simplifying the journey towards creating a world in which virtually everyone and everything is intelligently connected, while bringing applications and AI to the edge of the network. Most service providers, equipment suppliers, system integrators and even hyperscalers have adopted or advocated for similar solutions to various degrees either independently or in collaboration with the Company. However, to our knowledge, we are the first to market with patented technologies that a) bring virtualized data center capabilities to the far edge of the network, commonly referred to as the Device Edge, where all wired and wireless devices connect to the network, b) spawns hyperconvergence of computing, multiaccess communications and storage, c) provides for Cloud-managed applications at the Edge, d) enables machine learning with AI training, inferencing, and agentic AI at the Edge including AI-driven cybersecurity for heterogenous networks. Such networks are given rise through any combination of our developed devices and third-party devices, with CPUs, GPUs, TPUs, DPUs and/or NPUs, that run the Veea Edge PlatformÔ software stack.

Veea has developed several generations of highly integrated all-in-one devices that incorporate a Linux server, with a virtualized software environment, supporting our patented secured docker containers, together with a Wi-Fi Access Point with a mesh router, a firewall, an IoT gateway, NVMe data storage and 4G/5G modules, referred to as the "VeeaHub" product. With an extensive patent portfolio of approximately 125 granted patents and 25 pending patent applications that cover 26 patent families, our end-to-end Hybrid Edge-Cloud Computing platform represents a new product category that has the potential for wide scale customer adoption in large segments of consumer and enterprise markets.

VeeaONE Platform's products, applications, and services with a distributed computing architecture, offered as a Platform-as-a-Service capability, empower companies to capitalize on the transformative potential of Edge AI, where most of the data from smartphones, tablets, laptops, cameras, sensors, and other devices is generated, with data privacy and sovereignty, reliability, low latency for real-time decisions, bandwidth efficiency, scalability, and reduced costs compared to alternatives.

VeeaHub products, about the size of a typical Wi-Fi Access Point, are offered in variety of forms with different capabilities for indoor and outdoor coverage and are both locally- and cloud-managed. Veea Edge Platform architecture and business model, VeeaHubÒ and third-party devices on Veea Edge Platform with Hybrid Edge-Cloud Computing and AI-enabled applications and services resemble the Android OS platform architecture and business model for Android devices.

The VeeaONE Platform offers a complement, and in some cases an alternative, to cloud computing by enabling the formation of highly secure, but easily accessible, private clouds and networks across one or multiple user(s) or enterprise location(s) across the globe. Benefits of the Veea Edge Platform include optimal latency, lower data transport costs, data privacy, security and ownership, Edge AI, as well as "always-on" availability for mission critical applications, and contextual awareness for people, devices and things connected to the Internet.

Veea earns revenue primarily from the sale of its VeeaHub® devices, licenses, and subscriptions.

**Recent Developments**

***August 2025 Public Offering***

 ****

On August 14, 2025, the Company closed a public offering of 9,189,096 shares of common stock and warrants to purchase up to 9,189,096 shares of common stock at a combined offering price of $1.00 per share and accompanying warrant (the "August 2025 Public Offering"). The Company received aggregate cash gross process of approximately $6.0 million, before deducting placement agent fees and other offering expenses. The warrants have an exercise price of $1.10 per share, are exercisable immediately, and will expire five years from the original issuance date. Included in the aggregate securities issued are 3,239,096 shares of common stock and accompanying warrants that were issued to NLabs Inc. in consideration and satisfaction of the NLabs 2025 Notes. The Company is using the net proceeds from the August 2025 Public Offering for investments in inventory and the Company's customer support infrastructure and for other working capital and general corporate purposes.

***Supply Agreement***

On August 7, 2025, Private Veea entered into a Framework Agreement for the Licenses, Equipment and Services (the "Supply Agreement") with RadioMovil Dipsa, S.A. De C.V. ("Telcel"), a Mexican wireless telecommunications company owned by América Móvil, effective August 7, 2025. The Supply Agreement was signed by the parties following the completion of an extensive certification and homologation process with Telcel; and the successful completion of trials with certain Telcel enterprise customers of the Company's VeeaHub STAXÒ -5G product, incorporating Telcel SIM cards.

The Supply Agreement sets forth the general guidelines, terms and conditions that govern the solution implementation and marketing, as well as the provisioning of the services provided by VeeaSystems. Under the agreement, VeeaSystems will supply a comprehensive Platform-as-a-Service solution featuring 5G-based Fixed Wireless Access (FWA) through its VeeaHub STAXÒ-5G device, which incorporates 4G and 5G cellular connectivity, Wi-Fi 6 Access Point, IoT gateway, storage and Linux server capabilities to deliver connectivity with integrated AI-driven cybersecurity services, managed connectivity, and monitoring tools while capable of hosting applications on STAX-5G including third-party application. The parties have agreed to work together in the development of the marketing strategy, branding and promotion of Private Veea's services to Telcel's customers in Mexico. The agreement provides for an initial term of three years and automatically renews for successive one-year terms, unless either party elects not to renew upon 90-day prior notice.

 ****

***Appointment of Acting Chief Financial Officer***

On July 15, 2025, Randal V. Stephenson was appointed as the Company's Acting Chief Financial Officer.

***Appointment of Acting Chief Revenue Officer***

On July 15, 2025, Mr. Helder Antunes, a current member of the Company's Board of Directors, was appointed as the acting Chief Revenue Officer.

***Acquisition of Assets of Crowdkeep, Inc.***

*Asset Purchase Agreement* 

On May 13, 2025, the Company entered into an Asset Purchase Agreement with Crowdkeep, Inc., a Delaware corporation (the "Seller"), pursuant to which, subject to the terms and conditions set forth in the APA, the Company acquired upon the closing certain assets of Seller relating to Seller's IoT technology platform business, free and clear of any liens other than certain specified liabilities of Seller that are being assumed in consideration for the issuance to the Seller of 4,065,689 shares of common stock.

*Note Purchase Agreements and Convertible Promissory Notes*

On April 17, 2025, and May 13, 2025, the Company and the majority stockholder of the Seller ("Crowdkeep Investor"), entered into two Note Purchase Agreements (the "Crowdkeep Note Purchase Agreements"). Pursuant to the Crowdkeep Note Purchase Agreements, the Crowdkeep Investor loaned to the Company an aggregate of $1,000,000 in two tranches (the "Crowdkeep Loans"), of which $500,000 was provided on April 17, 2025 and $500,000 was provided on May 13, 2025. In connection with the entry into the Crowdkeep Note Purchase Agreements, the Company issued to the Crowdkeep Investor unsecured convertible promissory notes (the "Crowdkeep Convertible Notes"). The Crowdkeep Convertible Notes have an aggregate principal amount of $1,000,000, and the interest accrues at an annual rate of 8%. The maturity dates of the Crowdkeep Convertible Notes are April 17, 2026, and May 13, 2026, respectively.

Pursuant to the terms of the Convertible Notes, upon an event of default, the outstanding principal amount of the applicable Crowdkeep Convertible Note, plus accrued but unpaid interest, will become immediately due and payable in full. Events of default include failure to pay any principal or interest amounts under the Crowdkeep Convertible Notes, failure to perform covenants in the Crowdkeep Convertible Notes and certain bankruptcy and insolvency conditions of the Company. The Company may prepay all or any portion of the Crowdkeep Convertible Notes at any time. The Crowdkeep Convertible Notes are convertible, in whole or in part, into shares of the common stock (the "Crowdkeep Conversion Shares") at the option of the Crowdkeep Investor, at a price per share of $5.00 subject to certain equitable adjustments. The Crowdkeep Convertible Notes will automatically convert on the date that the closing price of the common stock is at $7.50 or above for ten (10) consecutive trading days within any consecutive thirty (30) trading day period, equal to the lesser of (i) $7.50 per share and (ii) 20% multiplied by the VWAP (calculated as set forth in the Crowdkeep Convertible Notes) for the prior consecutive thirty (30) trading day period, in each case subject to certain equitable adjustments. The Crowdkeep Note Purchase Agreements and Crowdkeep Convertible Notes include other customary terms and conditions.

*Lock-Up Agreements*

In connection with the Crowdkeep APA and the Crowdkeep Note Purchase Agreements, the Seller and the Crowdkeep Investor entered into lock-up agreements pursuant to which the Seller and the Crowdkeep Investor agreed not to effect any sale, distribution or transfer of any of the shares of Common Stock received in the transaction or any Crowdkeep Conversion Shares will be subject to transfer restrictions and restrictions against selling short or hedging the Company's securities for a period of six (6) months following the applicable closing of the APA or the Crowdkeep Note Purchase Agreement, respectively, subject to certain limited exceptions.

The form of lock-up agreement signed by the Seller is herein referred to as the "Crowdkeep Lock-Up Agreement" and the form of lock-up agreement signed by the Investor is herein referred to as the "Crowdkeep Noteholder Lock-Up Agreement." The Crowdkeep Lock-Up Agreement and the Crowdkeep Noteholder Lock-Up Agreement have substantially similar terms, but the Crowdkeep Lock-Up Agreement provides for distributions by the Seller to the Seller's stockholders, pro rata based on their ownership of Seller, subject to certain conditions.

**Components of Results of Operations**

***Sales, net***

The Company recognizes revenue based on the satisfaction of distinct obligations to transfer goods and services to customers. The Company generates revenue from hardware sales and the sale of licenses and subscriptions. The Company applies a five-step approach as defined in ASC 606, "*Revenue from Contracts with Customers*", in determining the amount and timing of revenue to be recognized: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when a corresponding performance obligation is satisfied. Most contracts with customers are to provide distinct products or services within a single contract. However, if a contract is separated into more than one performance obligation, the total transaction price is allocated to each performance obligation in an amount based on the estimated relative standalone selling price.

For licenses of technology, recognition of revenue is dependent upon whether the Company has delivered rights to the technology, and whether there are future performance obligations under the contract. Revenue from non-refundable upfront payments is recognized when the license is transferred to the customer and the Company has no other performance obligations. Revenue for licenses delivered under a subscription model having terms between one and twelve-months are recognized over time. Subscription revenue is generated through sales of monthly subscriptions. Customers pay in advance for the licenses and subscriptions. Revenue is initially deferred and is recognized using the straight-line method over the term of the applicable subscription period.

***Cost of Goods Sold***

 ****

Cost of goods sold consists primarily of the cost of finished goods, components purchased for manufacturing and freight. Cost of goods sold also includes third-party vendor costs related to cloud hosting fees.

***Operating Expenses***

 ****

We classify our operating expenses into the following categories:

● *Product development expenses*. Product development expenses primarily consist of employee compensation, employee benefits, stock-based compensation related to technology developers and product management employees, as well as fees paid for outside services and materials.

● *Sales and marketing expenses*. Sales and marketing expenses consist of compensation and other employee-related costs for personnel engaged in selling, marketing and sales support functions. Selling expenses also include marketing and the costs associated with customer evaluations. The Company does not currently incur advertising costs.

● *General and administrative expenses*. General and administrative expenses consist of compensation expense (including stock-based compensation expense) for employees and executive management, and expenses associated with finance, tax, and human resources. General and administrative expenses also includes transaction costs, expenses associated with facilities, information technology, external professional services, legal costs and settlement of legal claims and other administrative expenses.

● *Depreciation and amortization*: Depreciation and amortization expense consists of depreciation of Veea's property and equipment and amortization of Veea's patents and other intellectual property.

● *Impairment:* Impairment consists of impairment charges related to our in-process research and development ("IPR&D")

**Results of Operations**

The following tables set forth the results of our operations for the periods presented, as well as the changes between periods. The period-to-period comparison of financial results is not necessarily indicative of future results.

*F**or the three months ended September 30, 2025 compared to three months ended September 30, 2024 and the nine months ended September 30, 2025 compared to three months ended September 30, 2024***

The following table sets forth Veea's unaudited statements of operations data for the three and nine months ended September 30, 2025 and 2024, respectively. Veea has prepared the data on a consistent basis with the audited consolidated financial statements as of and for the years ended December 31, 2024 and 2023, included in the 2024 10-K. In the opinion of Veea's management, the unaudited three and nine month financial information reflects all necessary adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of this data.

---

| | | | |
|:---|:---|:---|:---|
|  | **For the Three Months Ended** | **For the Three Months Ended** | **%** |
|  | **September 30, <br> 2025** | **September 30,<br> 2024****Change** | **Change** |
| Revenues, net | $144926 | $50683 | 186% |
| Cost of Goods Sold | 53006 | 14997 | 253% |
| Gross profit | **91920** | **35686** |  |
| **Operating Expenses:** |  |  |  |
| Product development |  | 356761) | -100% |
| Sales and marketing | 15555 | 80937) | (81)% |
| General and administrative | 4522588 | 1989095 | 127% |
| Transaction costs including those incurred with contingent earn-out share liability |  | 55038544) | NM |
| Depreciation and amortization | 216436 | 67730 | 220% |
| **Total operating expenses** | **4754579** | **57533067** |  |
| **Loss from operations** | **(4622659)** | **(57497381)** |  |
| **Other Income (Expense):** |  |  |  |
| Other income | 879 | 8739) | (90)% |
| UK R&D tax credit | 1223328 | 1251243) | (2)% |
| Loss on initial issuance of convertible note |  | (1770933) | NM |
| Change in fair value of convertible note option liability | 270 | 607067) | NM |
| Change in fair value of warrant liabilities | 555498 | (220373) | NM |
| Change in fair value of Earn-Out Share Liability | 4720000 | 24750000) | (81)% |
| Other expense | (19155) | (36) | NM |
| Interest expense | (442867) | (451881) | (2)% |
| Total other income (expense) | **6037953** | **(24173826)** |  |
| Net income (loss) | $**1375294** | $**(33323555)** |  |

---

---

| | | | |
|:---|:---|:---|:---|
|  | **For the Nine Months Ended** | **For the Nine Months Ended** | **%** |
|  | **September 30,<br> 2025** | **September 30,<br> 2024****Change** | **Change** |
| Revenues, net | $232094 | $108264 | 114% |
| Cost of Goods Sold | 58156 | 57687 | 1% |
| Gross profit | **173938** | **50577** |  |
| **Operating Expenses:** |  |  |  |
| Product development | 164878 | 1152930) | -86% |
| Sales and marketing | 364856 | 459341) | -21% |
| General and administrative | 14531883 | 13091503 | 11% |
| Transaction costs including those incurred with contingent earn-out share liability | 25000 | 55038544) | NM |
| Depreciation and amortization | 421096 | 205111 | 105% |
| **Total operating expenses** | **15507713** | **69947429** |  |
| **Loss from operations** | **(15333775)** | **(69896852)** |  |
| **Other Income (Expense):** |  |  |  |
| Other income, net | 2112 | 21398) | (90)% |
| UK R&D tax credit | 1223328 | 1251243) | (2)% |
| Loss on initial issuance of convertible note |  | (1770933) | NM |
| Change in fair value of convertible note option liability | 60000 | 607067) | (90)% |
| Change in fair value of warrant liabilities | 660622 | (220373) | NM |
| Change in fair value of Earn-Out Share Liability | 13520000 | 24750000) | (45)% |
| Other expense | (46351) | (9346) | NM |
| Interest expense | (1822448) | (1352823) | 35% |
| Total other income (expense) | **13597263** | **23276233** |  |
| Net income (loss) | $**(1736512)** | $**(46620619)** |  |

---

***Revenue, net***

 ****

The Company generated revenue of $144,926 and $50,683 for the three months ended September 30, 2025 and 2024, and revenue of $232,094 and $108,264 for the nine months ended September 30, 2025 and 2024, respectively. Revenue has been principally earned from paid pilots for our VeeaHub<sup>®</sup> devices. Our focus over the past several years has been on field testing and refining our product to meet customer needs as well as market developments. As a result of these efforts, we expect revenue to grow over the next several quarters through the sales of our hardware, licenses and subscriptions. We are especially focused in four principal market opportunities: 1) Digital Equity and Inclusion, 2) Energy and Sustainability solutions for Smart Buildings and Climate Smart Agriculture, 3) Convergence of Fixed, Wireless, and 5G Networks, and 4) Smart Retail and Smart Warehouses.

***Cost of Goods Sold***

 ****

Cost of goods sold increased by $38,009, or 253%, in the three months ended September 30, 2025, compared to the three months ended September 30, 2024. Cost of goods sold stayed flat for the nine months ended September 30, 2025, compared to the nine months ended September 30, 2024. The disparity is primarily related to an increase in service-based revenue in the quarter.

***Product Development Expense***

 ****

Product development expense decreased by $356,761 or 100%, in the three months ended September 30, 2025 compared to the three months ended September 30, 2024 and decreased by $988,052 or 86%, in the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024. The decrease in product development expenses was due to decreased internal development costs during the period.

***Sales and Marketing Expense***

Sales and marketing expense decreased by $65,382 or 81%, in the three months ended September 30, 2025 compared to the three months ended September 30, 2024 and sales and marketing expense decreased by $94,485, or 21%, in the nine months ended September 30, 2025, compared to the nine months ended September 30, 2024. The decrease is primarily due to a reduction in unpaid customer pilots.

***General and Administrative Expense***

 ****

General and administrative expense increased by $2,533,495, or 127%, in the three months ended September 30, 2025 compared to the three months ended September 30, 2024 and increased by $1,440,379, or 11%, in the nine months ended September 30, 2025, compared to the nine months ended September 30, 2024. The increase is primarily related to certain non-capitalized expenses associated with the August 2025 Public Offering, and increased costs of additional personnel, resources, and administrative costs associated with the Company's sales activities.

  ****

***Depreciation and Amortization***

Depreciation and amortization increased by $148,704 or 220%, in the three months ended September 30, 2025 compared to the three months ended September 30, 2024 and increased by $215,985 or 105%, in the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024. The increase was due to additional amortization for the technology assets acquired from Crowdkeep, Inc. in May 2025.

***Other income, net***

 ****

Other income, net relates to immaterial non-operating transactions incurred during the period. These amounts were immaterial for the three months ended September 30, 2025 and 2024 and nine months ended September 30, 2025 and 2024.

***Change in fair value of derivative liabilities***

 ****

Change in fair value of derivative liabilities is comprised of the fair value adjustments to the convertible note option liability, SPAC Private Placement Warrants, the Earn-Out Share Liability, and the 2025 Investors Warrants at balance sheet date. The gain on the change in fair value of conversion note option liability of $270 for the nine months ended September 30, 2025, was determined using a Black-Scholes option pricing model. The gain on the change in fair value of the SPAC Private Placement Warrant of $555,498 for the nine months ended September 30, 2025, was determined based on the trading value of the Public Warrants and the Black-Scholes option pricing model. The gain on the change in fair value of the Earn-Out Share Liability of $4,720,000 for the nine months ended September 30, 2025, was determined using a Monte Carlo simulation. A significant driver of the changes in fair value was due to the decline in the Company's stock price.

 **

***Other expense***

 **

Other expenses relate to immaterial non-operating expenses incurred during the period. These amounts were immaterial for the three months ended September 30, 2025 and 2024 and nine months ended September 30, 2025 and 2024.

***Interest expense***

 ****

Interest expense decreased by $9,014 or 2%, in the three months ended September 30, 2025 compared to the three months ended September 30, 2024. Interest expense increased by $469,625, or 35%, in the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024. The increase was due to additional draws on our revolving line of credit and new related party notes entered into during the nine months ended September 30, 2025.

**Liquidity and Capital Resources**

During the three months ended September 30, 2025 and 2024, we incurred operating losses of $4.7 million and $57.5 million, respectively, and during the nine months ended September 30, 2025 and 2024, we incurred operating losses of $15.3 million and $69.9 million, respectively, and had an accumulated deficit of $219.6 million as of September 30, 2025. Since our inception, we have incurred significant operating losses and negative cash flows. The Company expects to continue to incur net losses as it continues to grow and scale its business. As of September 30, 2025, we had cash of $1,071,151 and outstanding debt of $17.5 million, of which $750,000 was outstanding under the September 2024 Notes, $1.0 million was outstanding under the unsecured convertible promissory notes issued by the Company to the majority stockholder of Crowdkeep in May 2025, $14.0 million was outstanding under the working capital facility, and $1.8 million was outstanding under a notes payable with an inventory vendor.

Although the Company has had recurring losses each year since inception, the Company plans to fund its operations and capital funding needs for the next 12 months with revenue generated from operations and through a combination of private and public equity offerings including, without limitation, anticipated revenue generated under the Supply Agreement entered into with Telcel, the proceeds of the August 2025 Public Offering completed on August 14, 2025, receipt of the cash tax refund of approximately $1.2 million in respect of the Company's UK subsidiary's 2023 and 2024 research and development activities, and potential additional investments in the form of debt or equity to fund operating deficits from existing and/or new investors, including related parties, which may include the Company's CEO and his affiliates.

Based in part on the above-referenced opportunities and initiatives, the Company has a reasonable basis to believe it has alleviated substantial doubt regarding its ability to continue as a going concern. Although management continues to pursue these plans, there is no assurance that the Company will be successful in obtaining sufficient funding on terms acceptable to the Company, if at all.

**Non-GAAP Financial Measures**

To supplement our consolidated financial statements, which are prepared and presented in accordance with GAAP, we use Adjusted EBITDA, as described below, to understand and evaluate our core operating performance. These non-GAAP financial measures, which may differ from similarly titled measures used by other companies, is presented to enhance investors' overall understanding of our financial performance and should not be considered a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP.

 ****

***Adjusted EBITDA***

The primary financial measure we use is Adjusted EBITDA. EBITDA is defined as net (loss) income, before interest, taxes, depreciation, and amortization. We define Adjusted EBITDA as net (loss) income excluding income tax provision, interest expense, net of interest income from related party loans, depreciation and amortization, stock-based compensation expense, and non-core expenses/losses (gains), including transaction-related costs, litigation-related costs, management fees, changes in fair value of liabilities, change in fair value of earn-out share liabilities and other expense, which includes asset impairments. Our management uses this measure internally to evaluate the performance of our business and this measure is one of the primary metrics by which our internal budgets are based. We exclude the above items as some are non-cash in nature, and others are non-recurring that they may not be representative of normal operating results. This non-GAAP financial measure adjusts for the impact of items that we do not consider indicative of the operational performance of our business. While we believe that this non-GAAP financial measure is useful in evaluating our business, this information should be considered as supplemental in nature and is not meant as a substitute for the related financial information prepared and presented in accordance with GAAP.

The following table provides a reconciliation of net loss to adjusted EBITDA to net loss for the periods presented:

---

| | | |
|:---|:---|:---|
|  | **For the three Months Ended** | **For the three Months Ended** |
|  | **September 30,<br> 2025** | **September 30,<br> 2024** |
| **ADJUSTED EBITDA:** | | |
| Net income (loss) | $1375294 | $(33323555) |
| Adjustments: |  |  |
| &nbsp;&nbsp;&nbsp;UK R&D tax credit | (1223328) | (1251243) |
| &nbsp;&nbsp;&nbsp;Interest expense | 442867 | 451881 |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 216434 | 67730 |
| **EBITDA** | **811266** | **(34055187)** |
| &nbsp;&nbsp;&nbsp;Other income, net | (879) | (8739) |
| &nbsp;&nbsp;&nbsp;Other expense | 19155 | 36 |
| &nbsp;&nbsp;&nbsp;Loss of initial issuance of convertible note |  | 1770933 |
| &nbsp;&nbsp;&nbsp;Change in fair value of conversion note option liability | (270) | (607067) |
| &nbsp;&nbsp;&nbsp;Change in fair value of warrant liabilities | (555498) | 220373 |
| &nbsp;&nbsp;&nbsp;Change in fair value of Earn Out Shares Liability | (4720000) | (24750000) |
| &nbsp;&nbsp;&nbsp;Transaction costs |  | 55038544 |
| &nbsp;&nbsp;&nbsp;Share-based compensation | 319211 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;59385 |
| **ADJUSTED EBITDA** | $**(4127015)** | $**(2331722)** |

---

---

| | | |
|:---|:---|:---|
|  | **For the nine Months Ended** | **For the nine Months Ended** |
|  | **September 30,<br> 2025** | **September 30,<br> 2024** |
| **ADJUSTED EBITDA:** | | |
| Net loss | $(1736512) | $(46620619) |
| Adjustments: |  |  |
| &nbsp;&nbsp;&nbsp;UK R&D tax credit | (1223328) | (1251243) |
| &nbsp;&nbsp;&nbsp;Interest expense | 1822448 | 1352823 |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 421096 | 205111 |
| **EBITDA** | **(716296)** | **(46313928)** |
| &nbsp;&nbsp;&nbsp;Other income, net | (2112) | (21398) |
| &nbsp;&nbsp;&nbsp;Other expense | 46351 | 9346 |
| &nbsp;&nbsp;&nbsp;Loss of initial issuance of convertible note |  | 1770933 |
| &nbsp;&nbsp;&nbsp;Change in fair value of conversion note option liability | (60000) | (607067) |
| &nbsp;&nbsp;&nbsp;Change in fair value of warrant liabilities | (660622) | 220373 |
| &nbsp;&nbsp;&nbsp;Change in fair value of Earn-Out Share Liability | (13520000) | (24750000) |
| &nbsp;&nbsp;&nbsp;Transaction costs | 25000 | 55038544 |
| &nbsp;&nbsp;&nbsp;Share-based compensation | 759123 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;394234 |
| **ADJUSTED EBITDA** | $**(14128556)** | **(14258963)** |

---

**Item 3. Quantitative and Qualitative Disclosures about Market Risk**

Not Applicable. As a smaller reporting company, we are not required to provide the information required by this Item.

**Item 4. Controls and Procedures**

*Evaluation of Disclosure Controls and Procedures*

Our management, with the participation and supervision of our Chief Executive Officer and our Acting Chief Financial Officer, have evaluated our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on that evaluation, our Chief Executive Officer and our Acting Chief Financial Officer have concluded that, as of the end of the period covered by this Quarterly Report on Form 10-Q, our disclosure controls and procedures were effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Acting Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

*Changes in Internal Control over Financial Reporting*

There were no changes in our internal control over financial reporting that occurred during our fiscal quarter ended September 30, 2025, that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

**PART II. OTHER INFORMATION**

**Item 1. Legal Proceedings**

From time to time, we may become involved in actions, claims, suits and other legal proceedings arising in the ordinary course of our business. We are not currently a party to any actions, claims, suits or other legal proceedings, the outcome of which, if determined adversely to us, would individually or in the aggregate have a material adverse effect on our business, financial condition and results of operations.

**Item 1A. Risk Factors**

We are a smaller reporting company and accordingly we are not required to provide information required by this Item. Risk factors that may affect our business and financial results are discussed within Item 1A "Risk Factors" of our annual report on the 2024 10-K. There have been no material changes to the disclosures relating to this item from those set forth in our 2024 10-K, other than as set forth below.

***Our failure to meet the listing standards of the Nasdaq Stock Market LLC ("Nasdaq") could result in the delisting of our common stock and publicly traded warrants (the "Public Warrants"). Delisting could adversely affect the liquidity of our common stock and the market price of our common stock could decrease, and our ability to obtain sufficient additional capital to fund our operations and to continue to operate as a going concern would be substantially impaired.*** 

 ****

On September 29, 2025, we received a notice from the Listing Qualifications Department (the "Staff") of Nasdaq, notifying us that, because the closing bid price for its common stock has fallen below $1.00 per share for 30 consecutive business days, we no longer comply with the minimum bid price requirement for continued listing on the Nasdaq Global Market under Nasdaq Lising Rule 5550(a)(2) (the "Minimum Bid Price Requirement"). The notice has no immediate effect on the listing of our common stock and Public Warrants on the Nasdaq Global Market and the common stock and the Public Warrants will continue to trade on The Nasdaq Global Market under the symbols "VEEA" and "VEEAW," respectively, at this time. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), we have been provided an initial compliance period of 180 calendar days, or until March 30, 2026, to regain compliance with the Minimum Bid Price Requirement. To regain compliance, the closing bid price of our common stock must meet or exceed $1.00 per share for a minimum of 10 consecutive business days prior to March 30, 2026; provided, however, pursuant to Nasdaq Listing Rule 5810 (c)(3)(H), Nasdaq may, in its discretion, require us to satisfy the Minimum Bid Price Requirement for a period in excess of ten consecutive business days, but generally not more than 20 consecutive business days, before determining that we have demonstrated an ability to maintain long-term compliance with the Minimum Bid Price Requirement.

On September 29, 2025, we received a notice from the Staff notifying us that, based on the market value of publicly held shares for the previous 30 consecutive business days, the listing of our listed securities was not in compliance with Nasdaq Listing Rule 5450(b)(2)(C) to maintain a minimum market value of publicly held shares of $15,000,000 (the "MVPHS Rule"). The notice has no immediate effect on the listing of our securities on The Nasdaq Global Market and the securities will continue to trade on The Nasdaq Global Market at this time. Pursuant to Nasdaq Listing Rule 5810(c)(3)(D), we have been provided a period of 180 calendar days, or until March 30, 2026, to regain compliance with the MVPHS Rule. To regain compliance during this 180-day compliance period, the minimum market value of publicly held shares must close at $15,000,000 or more for a minimum of 10 consecutive business days.

On September 29, 2025, we received a deficiency letter from the Staff notifying the Company that, for at least 30 consecutive business days, our Market Value of Listed Securities ("MVLS") was below the $50 million minimum requirement for continued inclusion on The Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(b)(2)(A) (the "MVLS Requirement"). The notice has no immediate effect on the listing of our securities on The Nasdaq Global Market and the securities will continue to trade on The Nasdaq Global Market at this time. Pursuant to Nasdaq Listing Rule 5810(c)(3)(C), we have been provided a period of 180 calendar days, or until March 30, 2026, to regain compliance with the MVLS Requirement. If at anytime during this compliance period our MVLS closes at $50 million or more for a minimum of ten consecutive business days, Nasdaq will provide us written confirmation of compliance. If we do not regain compliance with the MVLS Requirement, its securities will be subject to delisting.

There can be no assurance that we will continue to meet the Bid Price Requirement, the MVPHS Rule, the MVLS Requirement or any other Nasdaq continued listing requirements, in the future. If we fail to meet any of these requirements, including the Bid Price Requirement, the MVPHS Rule or the MVLS Requirement, Nasdaq may again notify us that we have failed to meet the minimum listing requirements and initiate the delisting process. If our common stock were delisted from Nasdaq, trading of our common stock and Public Warrants could be conducted in the over-the-counter market or on an electronic bulletin board established for unlisted securities such as the Pink Sheets or the OTC Bulletin Board, but there can be no assurance that our common stock and Public Warrants will be eligible for trading on such alternative exchange or market. Additionally, if our common stock were delisted from Nasdaq, the liquidity of our common stock would be adversely affected, the market price of our common stock could decrease, our ability to obtain sufficient additional capital to fund our operations and to continue to operate as a going concern would be substantially impaired and transactions in our common stock could lose federal preemption of state securities laws. Furthermore, there could also be a further reduction in our coverage by securities analysts and the news media and broker-dealers may be deterred from making a market in or otherwise seeking or generating interest in our common stock, which could cause the price of our common stock to decline further. Moreover, delisting may also negatively affect our collaborators', vendors', suppliers' and employees' confidence in us and employee morale.

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds**

None.

**Item 3. Defaults Upon Senior Securities**

None.

**Item 4. Mine Safety Disclosures**

Not applicable.

**Item 5. Other Information**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(c) Insider Trading Arrangements*

Trading Plans

None.

**Item 6. Exhibits**

---

| | |
|:---|:---|
| **Exhibit No**. | **Description** |
| 31.1\* | [Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](ea026505101ex31-1_veeainc.htm) |
| 31.2\* | [Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](ea026505101ex31-2_veeainc.htm) |
| 32.1\*\* | [Certification of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](ea026505101ex32-1_veeainc.htm) |
| 32.2\*\* | [Certification of the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](ea026505101ex32-2_veeainc.htm) |
| 101.INS\* | Inline XBRL Instance Document. |
| 101.SCH\* | Inline XBRL Taxonomy Extension Schema Document |
| 101.CAL\* | Inline XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.LAB\* | Inline XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE\* | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| 101.DEF\* | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| 104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |

---

\* Filed herewith. <br> \*\* Furnished, not filed

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

**VEEA INC.**

---

| | |
|:---|:---|
| By: | */s/ Allen Salmasi* |
|  | Allen Salmasi |
|  | Chief Executive Officer and Chairman |
|  | (Principal Executive Officer) |
| Date: | Date: |
| By: | */s/ Randal V. Stephenson* |
|  | Randal V. Stephenson |
|  | Acting Chief Financial Officer |
|  | (Principal Financial Officer and |
|  | Principal Accounting Officer) |
| November 14, 2025 | November 14, 2025 |

---

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATION OF THE**

**PRINCIPAL EXECUTIVE OFFICER**

**PURSUANT TO**

**RULE 13a-14(a) AND RULE 15d-14(a)**

**UNDER THE**

**SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO**

**SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Allen Salmasi, Chief Executive Officer of Veea Inc., certify that:

&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed the Quarterly Report on Form 10-Q of Veea Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and audit committee of the registrant's board of directors (or persons performing equivalent function):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: November 14, 2025 | */s/ Allen Salmasi* |
|  | Allen Salmasi |
|  | Chief Executive Officer |
|  | *(Principal Executive Officer)* |

---

## Exhibit 31.2

**Exhibit 31.2**

**CERTIFICATION OF THE**

**PRINCIPAL FINANCIAL OFFICER**

**PURSUANT TO**

**RULE 13a-14(a) AND RULE 15d-14(a)**

**UNDER THE**

**SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO**

**SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Randal V. Stephenson, Acting Chief Financial Officer of Veea Inc. certify that:

&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this Quarterly Report on Form 10-Q of Veea Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: November 14, 2025 | */s/ Randal V. Stephenson* |
|  | Randal V. Stephenson |
|  | Acting Chief Financial Officer |
|  | *(Principal Financial Officer and <br> Principal Accounting Officer)* |

---

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION OF THE**

**PRINCIPAL EXECUTIVE OFFICER**

**PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of Veea Inc. (the "Company") on Form 10-Q for the three months ended September 30, 2025, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Allen Salmasi, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company as of and for the period covered by the report.

---

| | |
|:---|:---|
| Date: November 14, 2025 | */s/ Allen Salmasi* |
|  | Allen Salmasi |
|  | Chief Executive Officer |
|  | *(Principal Executive Officer)* |

---

## Exhibit 32.2

**Exhibit 32.2**

**CERTIFICATION OF THE**

**PRINCIPAL FINANCIAL OFFICER**

**PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of Veea Inc. (the "Company") on Form 10-Q for the three months ended September 30, 2025, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Randal V. Stephenson, Acting Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company as of and for the period covered by the Report.

---

| | |
|:---|:---|
| Date: November 14, 2025 | */s/ Randal V. Stephenson* |
|  | Randal V. Stephenson |
|  | Acting Chief Financial Officer |
|  | *(Principal Financial Officer and <br> Principal Accounting Officer)* |

---